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ABSTRACT
FACTORS INFLUENCING THE OXIDATION OF 
LIPOPROTEINS AND PLASMA 
By
Yanshan Ma
The hypothesis that antioxidant vitamins (ascorbate and tocopherols) 
along with urate protect blood plasma lipids from oxidation was tested. Dietary 
fat is also an Important factor Influencing plasma lipid peroxidation. The purpose 
of this study was to Investigate the role of plasma antioxidants and dietary fat on 
low density lipoprotein (LDL) and plasma lipid oxidation.
In the first part of this study, we oompared the ability of urate and ascor­
bate to protect human LDL from in vitro oxidation. LDL oxidation was Initiated by 
15 mM of a  water soluble azo-inttlator In the presence or absence of ascorbate 
or urate. The rate of lipid hydroperoxide (LOOH) formation was increased after 
the LDL tocopherols were totally consumed, I.e., after the lag phase. Urate (50 
pM) was more effective than ascorbate (50 pM) In extending the lag phase. 
Moreover, urate was consumed more slowly than ascorbate under identical 
oxidation conditions. The combination of 25 pM ascorbate and 25 pM urate was 
more effective in extending the lag phase than ascorbate alone but less effective 
than urate alone. An empirical mathematical model was developed to describe 
the oxidation kinetics of LDL tocopherols.
In the second part of this study, we studied the role of dietary fat and 
dietary a-tocopherol (a-toc) levels on rat plasma oxidation. The fatty add 
composition of plasma was found to be modulated by the type of dietary fat. 
Neither dietary fat nor a-toc Influenced the plasma levels of water soluble 
antloxldants (ascorbate, urate and sutfhydryl content). Rat plasma was oxidized 
either by a  water soluble azo-inttlator (25 mM) or a  lipid soluble azo-lnltlator (10 
mM). In both cases, the rate of LOOH formation In plasma from rats fed butter 
oil diets w as markedly suppressed compared to the plasma from rats fed com oil 
diets. When oxidation was initiated by a llptd soluble azo-lnltlator, plasma from 
rats fed a-toc supplemented diets showed higher LOOH levels than plasma from 
rats fed a-toc deficient diets. Surprisingly, when oxidation was Initiated by water 
soluble azo-lnltlator, tocopherol appeared to act a s  a pro-oxidant.
The results suggest that urate may be more significant than ascorbate In 
delaying the consumption of tocopherols In human LDL and that low dietary 
PUFAs levels are more Important In preventing the in vitro oxidation of plasma 
lipids than high dietary levels of a-tocopherol.
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CHAPTER 1 
Introduction
Oxidation of Lipoproteins and Atherosclerosis 
Lipoproteins are a  group of Ifpld transport macromolecules that consist of 
a  core of hydrophobic lipids surrounded by polar llptds and apoproteins. The 
major classes of lipoproteins, In increasing order of density, are chylomicrons, 
very low-densfty lipoproteins (VLDL), low-denslty lipoproteins (LDL) and high 
density of lipoproteins (MDL). LDL, the major cholesterol-bearing lipoprotein in 
human plasma is a  large spherical particle. Its hydrophobic core consists of 
cholesteryt ester in which each cholesterol molecule is attached by an ester 
linkage to a  long-chain fatty acid. The surrounding amphlpathlc monolayer 
contains phospholipids with their head groups on the outer surface, unesterified 
cholesterol molecules and apoprotein B-100 which stabilizes LDL in the 
aqueous environment. LDL contains large amounts of poly-unsaturated fatty 
acids (PUFAs), i.e., C18:2n6, C18:3n3 and C20:4n6 which render LDL 
susceptible to peroxldatioa
Oxidative modification of LDL is implicated in the pathogenesis of 
atherosclerosis as recently proposed by Dr. Steinberg and his colleagues 
[Steinberg et al., 1989]. Atherosclerosis is a  complicated pathologic process in 
which environmental, nutritional, metabolic and genetic factors play important 
roles. Most vascular disease, such a s  cardiovascular and cerebrovascular 
d iseases are primarily caused by atherosclerosis which account for the largest
percentage of all deaths in Western society [Working group of atherosclerosis 
of the National Heart, Lung, and Blood Institute, 1981]. The major pathological 
change in atherosclerosis is the formation of atheromas or atherosclerotic 
plaques, which cause serious injury to the arterial wall and severe narrowing of 
the arterial lumen. It is not known how this process initially starts, 
atherosclerotic plaques, however, are generally found at branch points or 
bifurcations in large-sized and medium-sized arteries where fluid mechanical 
shear stress is high [Schwartz et al„ 1991]. The enhanced permeability of the 
endothelial lining facilitates accumulation of LDL in the subendothelium space 
which is thought to be the first step in atherogenesis [Meyers and Maloley, 
1993]. It was proposed that subendothelial accumulation of LDL may result 
from two processes: (1) the increased gaps between adjacent endothelial celts 
caused by elevated serum LDL levels allow LDL to leak into the 
subendothellum; (2) a  specific hlgh-affinHy receptor on the endothelial cells 
which causes LDL to reach the subendothelial space [Steinberg, 1983]. A 
number of studies have shown that LDL can be oxidized by incubation with 
cultured endothelial celts, smooth muscle celts and macrophages, all of which 
are normally found in the artery wait [Morel et at., 1984; Henriksen et al., 1983; 
Stelnbrecher et al., 1984; Parthasarathy et al., 1986a]. These findings 
suggested that once LDL reaches the subendothelial space it can be oxidatively 
modified by endothelial cells, monocytes and macrophages. Since plasma 
contains antioxidants capable of inhibiting LDL oxidation, the oxidation process
in vivo most likely takes place In the subendothelial space rather than In plasma 
[Chisolm, 1891].
Although the etiology of atherosclerosis Is not completely understood, 
increasing evidence suggests that oxidative damage to LDL plays an  important 
role. Oxidatively modified LDL (OM-LDL) Is more atherogenic than native LDL 
for a  number of reasons (see F1g.1). OM-LDL is a  chemo-attractant for blood 
monocytes which adhere to the endothelium and then penetrate to the 
subendothelium through gaps between endothelial cells [Quinn e t al., 1987]. 
Monocyte adhesion to endothelial cells is thought to be one of the earliest 
events in the atherogenesis. Within the subendothelial space, monocytes 
differentiate to m acrophages through an undefined process [Ross, 1986]. OM- 
LDL also inhibits the motility of macrophages in the artery wall and therefore 
Inhibits the ability of macrophages to leave the subendothelial space [Quinn et 
al„ 19851. OM-LDL is cytotoxic for cultured endothelial cells [Morel et al., 1983; 
Hennlg and Chow, 1988] and injury to endothelial cells may Induce platelet 
aggregation, adherence, and activation at the damaged site [Schwartz et al., 
1991; ArdUe et al., 1989; Bruckdorfer, 1989]. In addition, endothelial damage 
allows the blood elements to enter the subendothelium space thus facilitating 
the atherogenic process. Moreover, OM-LDL can directly activate platelets and 
cause secretion of platelet granules [Bruckdorfer, 1989]. It was also reported 
that OM-LDL Induced by Cu3* is more effective than native LDL In sensitizing 
platelets [Ardlie e t al„ 1989]. OM-LDL is rapidly taken up by the nonregulated
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Figure 1. A schematic outline showing the possible mechanisms whereby 
oxidatively modified LDL (OM-LDL) is more atherogenic than native LDL
scavenger receptor on m acrophages [Henriksen et al., 1981; Pahhasarathy et 
al., 1985]. The scavenger receptor Is distinct from the native LDL receptor and 
is neither saturated nor down-regulated by high concentration of OM-LDL 
[Goldstein e t al., 1979]. Only chemically modified forms of LDL, such as 
acetylated, malondialdehyde-conjugated, and oxidized LDL, but not native LDL, 
are recognized by the scavenger receptor [Steinberg et al., 1989]. A recent 
study suggests that there Is another type of receptor on m acrophages that 
recognizes only oxidized LDL but not other chemically modified forms of LDL 
[Sparrow et al., 1989]. Macrophages take up OM-LDL a t a  rate 3-10 times 
greater than native LDL [Henriksen et al., 1981]. Macrophages incubated with 
OM-LDL accumulate large amounts of cholesteryl esters and become lipid- 
engorged loam * cells. Foam cells a re  major components of fatty streaks which 
are thought to be the precursors of fibrous atherosclerotic plaques. OM-LDL 
can also be cytotoxic to macrophages and foam cells, therefore damaging 
these cells. The Intracellular OM-LDL, lysosomal enzymes and free radicals 
released from necrotic foam cells can further dam age adjacent cells and 
interstitial components which can lead to an Inflammatory process [Meyers and 
Maloley, 1993].
Recent studies suggest that OM-LDL Is present in vivo. Immuno- 
cytochemical techniques have shown that antibodies against OM-LDL recognize 
antigens In atherosclerotic lesions but not In normal sections of arteries 
[Haberiand et al., 1988; Palinskl, 1989,; Rosenfeld et al., 1990; Pal inski et al.,
1990]. Other convincing evidence for the presence In vivo of OM-LDL Is that 
antioxidants such a s  probucol (Carew et al., 1987; KHa et al., 1987] or butytated 
hydroxytoluene pjorkham et al., 1991] can inhibit the progression of 
atherosclerotic lesions in LDL receptor-deficient rabbits (WHHL rabbits) of 
cholesterol-fed rabbits. Probucol is able to lower plasma cholesterol levels and 
this effect alone may delay the development of atherosclerosis In the WHHL 
rabbits. Therefore, in the case  of the probucol study, the plasma cholesterol 
levels in both the control group and the probucol-supplemented group were 
adjusted to be the sam e so that the cholesterol-lowering effect of probucol 
could be balanced o u t It was shown that probucol inhibits the uptake and 
degradation of LDL In atherosclerotic lesions but not In normal arteries [Carew 
et al., 1987]. The findings that patients with atherosclerosis showed higher 
serum levels of lipid peroxides also suggest an in vivo role for OM-LDL 
[Stringer et al., 1989; Liu et al., 1992; Plachta et al., 1992].
Mechanism of Uoid peroxidation 
Upid peroxidation may be Initiated by a  primary free radical which Is a  
molecule or molecular fragment with an unpaired electron. In aerobic biological 
systems, the most important free radicals are superoxide anion (02*), peroxyl 
radicals (HOO), hydroxyl radicals (HO), alkyl radicals (R) and lipid peroxyl 
radicals derived from PUFAs (LOO) [Burton and Traber, 1990]. LDL contains 
large amount of PUFAs, i.e., C18:2n6, C18:3n3 or C20:4n6, which are very 
susceptible to lipid peroxidation. The mechanism of LDL lipid peroxidation is
likely to resemble the process that has been studied using artificial lipid 
substrates. As shown In Fig. 2, lipid peroxidation is initiated when a  radical 
Initiator abstracts a  hydrogen atom from a  PUFA segm ent (LH) present In the 
LDL (Initiation event). The resulting carbon-centered lipid radical stabilizes by 
isomerization to a  conjugated diene through double bond rearrangement. The 
lipid radical containing conjugated diene reacts rapidly with molecular oxygen to 
form a  lipid peroxy radical (LOO). In the absence of antioxidants, the peroxy 
radical will abstract a  hydrogen atom from an adjacent PUFA segm ent to yield 
a  lipid hydroperoxide (LOOH) and another fatty ad d  carbon-centered radical. 
The new carbon-centered radical can then continue the uncontrolled chain 
reaction over again, This propagation phase can be repeated many times 
prodded that molecular oxygen and unoxidized PUFA segm ents are present in 
the reaction system. Therefore, one initiation step can trigger numerous fatty 
ad d s  to form lipid hydroperoxides. Furthermore, the reaction may further 
accelerate because lipid hydroperoxides can be decomposed by transition metal 
Ion-catalyzed reactions and become radicals, such as lipid peroxyl radicals and 
alkoxyl radicals. These radicals can further initiate and propagate the lipid 
peroxidation. The termination of the propagation cycle occurs when peroxy 
radicals interact each other and interact with various free radical scavengers 
(e.g., antioxidants) resulting In non-radical, stable products.
Antioxidants andUpldOxldation 
Plasm a contains an array of antioxidants that can prevent the initiation of
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Figure 2. Mechanism of ilpid peroxidation.
chain reaction or Inhibit the extent of lipid peroxidation by trapping free radicals. 
These antioxidants include protein sutfhydryl groups, enzym es (superoxide 
dismutase, selenium-dependent glutathione peroxidase, catalase) and 
non enzymatic antioxidants, such a s  vitamin E, 8-carotene, lycopene, vitamin C 
(ascorbic add), glutathione and uric add . These antioxidants constitute a  
defense system against free radical damage.
Vitamin E is the major lipid soluble, chain-breaking antioxidant in plasma 
[Burton et a)., 1983; Ingold et al., 1987]. Naturally occurring vitamin E has eight 
different forms: alpha-, beta-, gamma-, delta-tocopherols and alpha-, beta-, 
gamma-, ddta-tocotrienois [Kayden and Traber, 1993]. All of the tocopherols 
have a  chromanoi ring and a  phytyl tali. They are dasslfied based on the 
number and position of methyl groups on the rings. Tocotrienols differ from 
tocopherols in their unsaturated tails. The major dietary sources of vitamin E 
are cereals, nuts and legumes [Hodges, 1979]. Untike other fat-soluble 
vitamins, vitamin E has no specific transport protein in plasma, but rather is 
carried by lipoproteins, particularly HDL and LDL [Behrens and Madere, 1985; 
Ogihara et at., 1988; Clevidence and Lehmann, 1989]. The major forms of 
dietary vitamin E in humans are alpha- and gamma-tocopherols (Fig. 3). The 
concentration of alpha-tocopherol in human plasma is usually 2 to 3 times 
higher than that of gamma-tocopherol. Alpha-tocopherol is the most potent 
antioxidant of the tocopherols. It reacts more quickly with peroxyl radicals than 
do other tocopherols or PUFAs [Burton and Ingold, 1986]. Kinetic studies using
10
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Figure 3. AJpba-tocopberol and gamma-tocopherol are major forms of vitamin E 
in human p lasm a They differ In the number and position of methy groups on 
the chromanol ring.
synthetic lipid substrates have shown that one molecule of tocopherol 
scavenges two molecules of peroxyl radicals [Yamamoto et al.,1984; Nlkf et al., 
1984; Burton and Ingold, 1981]. As shown In Flg.4, alpha-tocopherol donates 
its phenolic hydrogen atom to a  peroxyl radical and converts It to lipid 
hydroperoxide. The resulting tocopheroxyl radical is resonance-stabilized; 
therefore, it normally Is not thought to participate in chain propagation but 
scavenges another peroxyl radical thereby terminating the chain reaction. 
Several lines of evidence indicated that vitamin E, whether supplemented in 
diets or added in vitro, Is able to inhibit oxidation of LDL [Stone e t al„ 1986; 
Stone, 1968; DIeber-Rotheneder e t al., 1991; Jlalal and Grundy, 1992; Princen 
et al., 1992; Esterbauer et al., 1991]. Jesup  and his colleagues [Jesup et a l, 
1990] have shown that all the endogenous alpha-tocopherol in LDL must be 
oxidized before the LDL Is converted into a  form of OM-LDL capable of rapid 
uptake by macrophages In tissue culture. Recent studies suggest that one LDL 
particle, on average, contains six alpha-tocopherol molecules and one thousand 
molecules of PUFA [Janero, 1991]. One molecule of vitamin E Is estimated to 
protect about three thousand PUFA molecules against free radical injury [Gey 
e t al., 1987]. This protection, however, lasts for onfy a  relatively short time. 
Moreover, It Is very likely that LDL oxidation in vivo would be initiated by 
radicals generated In the aqueous phase. Water soluble antioxidants in plasma 
quench aqueous free radicals and should thereby inhibit LDL oxidation and the 
consumption of LDL tocopherols.
12
+  LOOH
Figure 4. Vitamin E (a-tocoptwof) is a  major lipid solubla antioxidant. Each 
molecule of a-tocophtro) can scavenge two molecules of peroxyl radicals 
(LOO*) and convert them into lipid hydroperoxides (LOOH) or stable product.
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Vitamin C (ascorbate) [3 a  water soluble antioxidant that effectively 
protects plasm a lipids from peroxldative damage caused by aqueous free 
radical species [Frel et al„ 1988; Frel et al., 1989; Frel, 1991; Niki, 1991]. Each 
ascorbate molecule can terminate 0.6 free radicals [Doba et al., 1985]. It was 
shown that ascorbate quenches aqueous peroxyl radicals with a  fast rate 
constant so  that most initiating free radicals can be trapped before they can 
diffuse into the lipid phase [Nik!, 1991]. Moreover, there is evidence suggesting 
that ascorbate can regenerate tocopherol from the tocopheroxyl radical in LDL 
at the llpfd-water Interface (Sato e t al., 1990; Kagan e t al., 1992; Kafyanaraman, 
1992]. Therefore, ascorbate and vitamin E may act together In preventing LDL 
oxidation.
CH ,O H  
H ► C ^  OH
OHHO
HN
NH
O
L-Ascorbic Acid Uric Acid
llrfc acid (urate at physiological pH), a  metabolic product of purine 
degradation, Is also an Important antioxidant in human plasma and tissues 
[Frei,1991; Ames et al., 1981; Cutler, 1991]. Ames et al. proposed that uric 
acid may have replaced some of the antioxidant functions of ascorbic ad d  since 
humans have lost the ability to synthesize ascorbate during evolution [Ames et 
al., 1981]. The loss of uricase activity, an enzyme that converts urate to form 
ailantoin, a s  wett a s  the development of an  active kidney reabsorption system 
for urate allows humans to have 10 times higher serum concentration of urate 
than most other mammals [Roch-Ramel, 1978]. Urate is capable of Inhibiting 
lipid peroxidation, In part, by chelating Iron and copper [Rice-Evans and 
Bruckdorfer, 1992]. Earlier studies had reported that urate can scavenge 
singlet oxygen and oxy-haem oxidants [Simon and Van Vunakis, 1964; Howell 
and Wyngaarden, 1960]. Urate can also protect the stability of linolelc add  
[Matsushita et al., 1963] and the Integrity of erythrocyte membrane [Kellogg and 
Fridovich, 1977].
There Is, however, little information concerning the comparative ability of 
urate and ascorbate to inhibit LDL oxidation. This is an  Important issue since 
plasma levels of urate (300*395 pM) In humans are about five to ten times 
higher than plasma levels of ascorbate (30-50 pM). In the first part of this 
research, we compared the ability of urate to protect human LDL from in vitro 
oxidation with that of ascorbate. W e also studied the combined effect of these 
two antioxtdants in protecting LDL from oxidation. The kinetics of LDL oxidation
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was measured In the absence of water-soluble antioxidants, in the presence of 
equimolar concentrations (50 pM) of either urate or ascorbate or In the 
presence of 25 pM urate combined with 25 pM ascorbate. An empirical 
mathematical model w as also developed to  describe the  oxidation kinetics of 
LDL alpha-tocopherol and gamma-tocopheroi in the presence or absence of 
urate or ascorbate.
Dietary Fat and Plasma Oxidation 
In addition to antioxidants, dietary fat-type may also be an important 
factor influencing lipid peroxidation. It is generally accepted that human health 
can be optimized by the long-term consumption of diets with PUFAs substituting 
for saturated fatty ad d s  (SFAs), since PUFAs have been demonstrated to lower 
plasma cholesterol levels [Mattson and Grundy, 1985; Grundy, 1975; Ahrens et 
al., 1957]. PUFAs, however, contain more double bonds and are, therefore, 
more susceptible to lipid peroxidation than SFAs or monounsaturated fatty adds 
(MUFAs). Fatty ad d  autoxldation requires at least two double bonds (I.e., a  
divinyl methane structure, CHafCH-CH*)^ and the rate of oxidation increases 
with the degree of polyunsaturation.
The fatty ad d  composition of plasma lipids is strongly Influenced by the 
fatty add  composition of dietary fat [HIral e t at., 1984; Parthasarathy et al., 
1990]. Hlrai et al. showed that plasma from rats fed a  1% cholesterol diet with 
20% butter oil had lower ratio of PUFA to SFA compared to plasma from rats 
fed identical diets but with either 20% cod liver oil or 20% wheat germ oil
replacing the butter oil [Hirai et al„ 1984]. Studies in African green monkeys 
showed that a  diet rich in linoleic acid resulted In llnolelc add-enriched LDL 
[Rudel et al., 1986]. Diets with a  high PUFA content should result In plasma 
lipids with a  high PUFA content and a  greater susceptibility to lipid peroxidation. 
LDL from rabbits fed a  diet rich in linoleic a d d  containing high PUFA content is 
more susceptible to oxidation than LDL from rabbits fed a  diet rich In oleic ad d  
containing high MUFAs [Parthasarathy et al., 1990]. Moreover, oxidative stress 
caused by PUFA-rich diets should be amplified by defldendes of plasma 
antloxldants, such a s  vitamin E, a  major lipid soluble antioxidant Hafeman and 
Hoekstra have shown that rats fed cod liver oil (high PUFA) and vitamin E 
deficient diets exhale more ethane, a  product formed during lipid peroxidation, 
than rats fed a  similar diet but rich in lard (very low PUFA) [Hafeman and 
Hoekstra, 1977]. A recent study in humans showed that a  fish oil diet without 
vitamin E supplementation results In LDL more susceptible to in vitro oxidation 
than a  fish oil (Set supplemented with vitamin E [Oostenbrug, 1993]. There is, 
however, little Information on the  potential influence of dietary fat and dietary 
vitamin E on plasma lipid oxidation.
Lipid peroxidation and vitamin E deficiency are known to influence the 
activity of plasma lecithin:cho!esterol acyttransferase (LCAT) and phospholipase 
As [Pappu et a)., 1978]. These enzymes are  important In the production of 
plasma fysoledthln. Lysoiedthln Is chemotactic for human monocytes. It 
inhibits the mobility of m acrophages in vitro and may, therefore, play a  role in
foam celt formation [Parthasarathy et al., 1986; Quinn e t al„ 1988]. It was 
shown that lysolecithin Impaired the endothelium-dependent relaxation of the 
vasculature [Schwartz e t al., 1986]. During LDL oxidation in vitro there Is an 
extensive hydrolysis of phosphatidylcholine at the 2-position through 
phosphollpase Aj resulting in increased lysolecithin formation [Steinbrecher et 
al., 1984]. Pappu et a), found that vitamin E deficiency in rats caused a  
dramatic reduction In plasma LCAT activity and an activation of phosphollpase 
As In liver mitochondria. The plasma level, however, of lysolecithin was not 
measured in their study.
A few lines of evidence, recently, suggested that ethanolamine 
ptasmalogens, a  group of glycerophosphollplds in plasma lipids, may play a  role 
in modulating oxidative stress to plasma lipids. In particular, ethanolamine 
plasmalogen (1-alk-1-enyl-2-acylglycerophosphoethanolamlnes or EtnPm) may 
function a s  an  antioxidant since these  lipids have a  vinyl ether linkage that can 
scavenge reactive oxygen species (Zoeller e t al., 1988; Vance, 1990]. This 
hypothesis, however, has not been critically tested. Moreover, It Is not known 
how dietary fat and dietary vitamin E deficiency Influence the lipid composition 
of plasm a phospholipids, especially the lysolecithin and EtnPm.
In the  second part of this research, w e investigated the Interaction 
between dietary PUFA content and dietary vitamin E intake in modulating the in 
vitro oxidation of plasma, as well a s  the lipid composition of plasma 
phospholipids. Rat plasma oxidation was initiated by azo-inttlator. Azo-Inftiators
are particularly useful for quantitative studies of oxidation kinetics because they 
decompose to  yield initiating free radicals a t known and constant rates. Two 
types of azo-inttiators were used In rat plasma oxidation. One is water soluble, 
I.e., 2,2*-azobte (2-admidinopropane) HCL (ABAP) and it generates free radicals 
In the aqueous environment; the other is lipid soluble, I.e., 2,2’ azobis- (2,4- 
dimethylvaleronitrile) (AMVN) and It generates free radicals within the lipid 
domain.
An animal model was utilized to test the following hypotheses: (1) plasma 
isolated from rats fed a  com oil diet (CO) high in PUFA would be more 
susceptible to in vitro lipid peroxidation than plasma isolated from rats fed a  
butter oil diet (BO) low in PUFA; (2) plasma from rats fed a  vitamin E deficient 
diet would be more susceptible to in vitro lipid peroxidation than plasm a from 
rats fed an  identical diet but supplemented with vitamin E; (3) plasma from rats 
fed vitamin E deficient diets (CO-E or BO-E) would have a  higher level of 
lysolecithin and a  lower content of plasmaiogen.
CHAPTER 2 
Materials and Methods
Part I -  The Influence of Plasm a Antioxidants on the Oxidation
Kinetics of Human Lipoprotein
Overall Experimental Deslon
Human LDL w as Isolated from Red Cross plasma by step-wise density 
ultracentrifugation. The purified LDL was subjected to In vitro oxidation at 30°C 
with an Oa saturated solution containing 15 mM water soluble azo-lnftlator, or 
ABAP. In parallel experiments, 50 pM ascorbate and 50 pM urate were added 
to the oxidation solution respectively. An additional experiment w as performed 
In which 25 pM ascorbate combined with 25 pM urate was present in the 
oxidation solution. The consumption of LDL vitamin E (alpha-tocopherol and 
gamma-tocopheroQ and formation of lipid hydroperoxide, a s  well a s  the 
disappearance of ascorbate and urate were m easured a s  a  function of time.
Chemicals
2,2'-Azobls (2-amtdinopropane) HQ (ABAP) was obtained from 
Polysciences, Inc. (Warrington, PA) and stored a t 4°C. Ascorbic a d d  (vitamin 
C) was purchased from Fluka Biochemika (Switzerland). Ethylenediamlne- 
tetraacetic ad d  (EDTA), urate and propyl gallate were obtained from Sigma 
Chemical Company (S t Louis, MO). Sodium dodecyl sulphate (SDS) was
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purchased from Hoefer Scientific Instruments (San Francisco, CA). Butylated 
hydroxy-toluene (BUT) was obtained from Aldrich Chemical Company, Inc 
(Milwaukee, Wl). Sodium chloride (NaCI), potassium bromide (KBr), HPLC 
grade methanol and hexane were purchased from Fisher Scientific (Fair Lawn, 
New Jersey). Absolute ethyl alcohol was obtained from Florida Distillers 
Company (Lake Alfred, FL). Tocol w as a generous gift from Hoffman-La Roche 
Chemical Co (Nutley, NJ). All chemicals were used as they came without 
further purification.
Lipoprotein preparation
Human plasma (1.0 mg EDTA/mQ collected from Individual healthy 
donors was obtained from American Red Cross. LDL (density range 1.019 
g/ml-1.063 g/mt) was Isolated by step-wise density uttracentrifugation using a  
Sorvall OTD-65B uttracentrifuge as previously described [Stone, 1975]. Plasma 
was centrifuged at 54,454 x g at 15 °C for 18 hrs In a  Beckman type 30 rotor. 
Chylomicron and VLDL (top layer) were removed. The density of the remaining 
plasma containing LDL and HDL was adjusted to 1.063 g/ml by adding solid 
KBr. After centrifuged at 4°C for 24 hr at 267,812 x g in a  Sorvall H865.1 rotor, 
the top LDL layer was collected. LDL was further purified by gel permeation 
chromatography on a  Sepharose CL-4B (Pharmacia Biotech Inc., Piscataway, 
NJ) column eluted with 0.15 M NaCI with 0.25 mM EDTA adjusted to pH 7.4. 
in addition to removing small amounts of albumin, this chromatographic step 
also removed any remaining ascorbate and urate from the LDL The LDL
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fractions were pooled, filtered through a  0.45 pm Acrodisc filter and stored at 
4°C under nitrogen until used (within one week).
SDS-Poh/acrvlamlde Gel Electrophoresis
The LDL purity w as checked by SDS-polyacrylamide gel electrophoresis 
SDS-PAGE). LDL fractions eluted by get permeation chromatography were 
used for electrophoresis. The gel electrophoresis was performed according to 
the method of Laemmli [Laemmli, 1970] using a  7.5% acrytamide gel at a 
constant current of 20 mA in a  Mighty Small II slab gel electrophoresis unit 
(Hoefer Scientific Instruments, San Francisco, CA). Gels were stained with 
Coomassie Blue R-250 and then destained with a  solution containing 10% 
methanol and 7.5% acetic add . SDS-PAGE indicated a  single apotipoprotein 
polypeptide with an electrophoretic mobility Identical to that of apoBIOO.
Determination of Protein Concentration
LDL protein w as determined by a  modification of the Lowry method 
[Markweil, e t al„ 1978] using bovine serum albumin a s  standard.
Upooroteln Oxidation
Five different plasma donors were used and the LDL from each donor 
w as independently subjected to the oxidation. Dialysis tubing was boiled and 
thoroughly rinsed with 0.1 mM EDTA to remove any trace metals. A 3.0 ml 
aliquot of LDL (0.5*1.0 mg protetn/ml) was placed inside the dialysis tubing with 
a  protruding length of mtcrobore teflon tubing a s  shown in Figure 5. After
no ascorbate 50 pM ascorbate 50 pM urate 25 pM ascorbate 
or urate + 25 |iM urate
30 °C
Figure 5. Human LDL oxidation systems in the absence or presence of water 
soluble antioxidants. LDL was placed inside the dialysis tubing which was placed 
in a  beaker. In each oxidation system, both LDL and the dialysate contained 15 
mM ABAP.
sealing, the dialysis tubing with LDL was placed In a  beaker containing 200 ml 
of 0.15 M NaCt/0.25 mM EDTA with 15.0 mM of a  water soluble azo-inftlator 
(azobIs-2-amldtnopropane HCL or ABAP) at pH 7.4. ABAP was also added to 
the LDL sample before the dialysis tubing was sealed giving a  final 
concentration of 15.0 mM. A second parallel LDL oxidation system w as 
assem bled but ascorbate (50 pM final concentration) was added to both the 
dialysate and the LDL sample. Similarly, a  third parallel LDL oxidation system 
had 50 pM urate. The stock ascorbate or urate solutions were m ade 
Immediately before each oxidation experiment using deaerated pH 7.4/0.15 M 
NaCt/ 0.25 mM EDTA solution. To study the combined effect of ascorbate and 
urate on LDL oxidation, an additional experiment w as performed using LDL 
from a  single additional donor. In addition to the 3 oxidation system s described 
above, a  fourth LDL oxidation system was se t up in which both of the dialysate 
and LDL sample contained both 25 pM ascorbate and 25 pM urate.
The oxidation experiment w as initiated (at 30 °C) immediately after the 
ABAP w as added to LDL by continuously bubbling filtered air through a  60 pm 
pore gas diffusing stone In each beaker. At each time point an aliquot of the 
LDL was withdrawn from the dialysis bag in each beaker (via the microbore 
tubing) and Immediately assayed for lipid hydroperoxides (in triplicate) and 
tocopherols. An aliquot of the dialysate w as also withdrawn from each beaker 
and used to determine the concentration of urate and ascorbate.
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Lipid Hydroperoxide Measurement
Liptd hydroperoxide levels were assayed using a  methylene blue 
derivative (10-N-methytearbamoyl-3,7-dimethylamino-10 H-phenothiazine or 
MCDP). The chemical mechanism of this assay  is illustrated in Figure 6. In the 
presence of hemoglobin (a reaction catalyst), lipid hydroperoxides 
stoichiometricalty react with the MCDP to produce methylene blue [Tatelshi e t 
al., 1987; Ohlshl e t al., 1985]. We used a  commercial kit available from Kamlya 
Biomedical Co. (Thousand Oaks, CA) that also contained Triton X-100, 
ascorbate oxidase (EC.1.10.3.3), and lipoprotein lipase (EC.3.1.1.34). We 
adopted this extremely sensitive and specific assay  to work with a  microtiter 
plate reader (Molecular Devices Corporation, Menlo Park, CA) [LeClair and 
Stone, 1991]. The assay was not interfered with by ABAP, tocopherol, urate or 
ascorbate a t the levels used In the experiments. The LDL used for the assay 
ranged from 5 to 30 pi. The blank used for each LDL lipid hydroperoxide assay 
was an aliquot (equal In volume to the LDL sample) of the dialysate obtained at 
the sam e time point
Consumption of aloha- and aamma-tocophetol
An allquote of LDL sample was mixed with ethanol containing tocol a s  an 
internal standard. Alpha- and gamma-tocopherol present in LDL were then 
immediately extracted Into hexane containing BHT (50 pg/ml). Following the 
extraction, the hexane layer was removed and then evaporated under a  gentle 
stream of nitrogen gas. The residue was dissolved In ethanol containing proryl
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Hydroperoxides Hemoglobin
H,C _  _  * . .  A .COOH I  H.C A A A A / COOH\ r y \ j w w *-> \ryuww
OOH /  \  OH
MCDP Methylene Blue
MCDP (Tentative Name) Methylene Blue (A max ■ 675 nm)
i
C - 0
I
NMI
CH,
MCDP; 16- N-Methyicarbamoyt-3,7-dimethylamIno-10 H-phenothiazine
Rgure 6. Mechanism of the colorimetric method for lipid hydroperoxide 
determination.
galleate (50 |xg/ml) a s  an  antioxidant Levels of alpha-tocopherol and gamma- 
tocopherol were measured using reverse phase HPLC with a  Ahex-Ultrasphere- 
ODS (Beckman Instruments, Inc., Fullerton, CA) 4.6 mm ID x 25 cm column 
[Bierf et al., 1979]. The mobile phase was methanol w ater (99.5%:0.5%, 
vol:voi). A McPherson Model FL-750 spectrofluorescence detector (McPherson 
instrument, acton, MA) was utilized with 294 nm excitation and 324 nm 
emission. Alpha-tocopherol, gamma-tocopherol and tocol In a  1:1:1 weight ratio 
gave peak areas with a  1.796:0.798:1.000 ratio using the fluorescent detector. 
Correction factors were, therefore, used to convert peak areas to nmotes of 
alpha- or gamma-tocopherol.
Determination of Ascorbate end Urate Concentration
The concentration of ascorbate and urate In the dialysate from each 
oxidation system was determined by recording the UV spectra with a  Milton 
Roy Model 3000 photodiode array spectrophotometer (Milton Roy Co., Marietta, 
GA). An extinction coefficient of 15,000 cnV’M*' at 265 nm [Lewin, 1976] was 
used for ascorbate and 11,220 cm‘1M 1 at 292 nm for urate.
For each human LDL oxidation experiment, the linear regression 
coefficients for time versus lipid hydroperoxide formation before and after the 
induction period was calculated using Sigma Plot Scientific Graph System 
(Jandel Scientific, Corte Madera, CA, USA). Standard statistical methods were
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employed to determine If the elopes, I.e., the rates of lipid hydroperoxide 
formation, were significantly different before and after the induction period 
[Edwards, 1979], The induction period w as the time required to totally consume 
all tocopherol. The m ean rates of lipid hydroperoxide formation from the six 
independent LDL oxidation experiments (In the presence or absence of urate or 
ascorbate) were also compared by a  one-way analysis of variance (ANOVA) 
followed by Scheffe’s  test for comparing multiple means. A p < 0.05 was 
considered a s  statistically significant.
The consumption of alpha-tocopherol and gamma-tocopherol for each 
oxidation experiment w as curve fit by nonlinear regression using the Marquardt- 
Levenberg algorithm provided by Sigma Plot Scientific Graph System. The 
modified sigmoidal equation (1) gave the best fit (see Results), 
toe (I) « (toe0 + bt)/(1+(t/c)d) (1)
The curve fit algorithm also provided the standard error for each parameter.
Part II -  The Role of Dietary Fat and Vitamin E on Rat Plasm a Oxidation
Overall Experimental Design
Male Fischer-344 rats were fed diets supplemented with or deficient In 
vitamin E (alpha-tocopherol) and containing high levels of either com oil or 
butter oil. Plasma w as collected and pooled from rats In different dietary group. 
Plasm a oxidation was Induced by either water soluble azo-inltiator (ABAP) or 
lipid soluble azo-lnltiator (AMVN). During oxidation, the lipid hydroperoxide
formation w as measured cdorimetrically a s  a  function of time. The alpha- 
tocopherol consumption In plasma from rats fed vitamin E supplemented diets 
was determined by reversed phased HPLC. Plasma fatty ad d  composition, 
plasma levels of triglyceride, cholesterol, ascorbate, urate and sulfhydryl group 
In Individual rats were measured. Plasma lipids from individual rats were 
extracted and analyzed for lysolecithin and plasmalogen content using thin layer 
chromatography (TLC).
C h e m ic a ls
2,2'-Azobis (2-amldinopropane) HCL (ABAP) and 2,2’-azo*bJs (2,4- 
dimethylvaleronitrile) (AMVN) w as obtained from Pofysdences, Inc. (Warrington, 
PA). Monobasic or dibasic sodium phosphate, cholesterol esterase, HR 
peroxidase, cholesterol oxidase, 5,5’-dithIobls*(2-nitrobenzoid add) (DTNB), 
cummene hydroperoxide, trichloracetic add , ascorbate oxidase, phenazine 
methosulphate, 3*(4,5-dimethytthiazolyl-2)-215-diphenyitetrazolium bromide 
(MTT), triton X-100, cupric sulfate and boron trifluoride were obtained from 
Sigma Chemical Company (S t Louis, MO). Sodium sulfate, chloroform, 
dichtoromethane, methanol, ammonium hydroxide (NH4OH) were purchased 
from Fisher Sdentitle (Fair Lawn, NJ). All chemicals were used a s  they cam e 
without further purification.
Animals and Diets.
Male Fischer-344 rats weighing 50-60 g were obtained from Charles
River’s Breeding Laboratories (Wilmington, MA). Rats were housed in 
suspended stainless steel wire-bottomed cages at 25 ± 2°C and 50% relative 
humidity and maintained on a  12 hr light-dark cycle. For the first two weeks, 
the rats were fed a  nonpurified diet (Rodent Laboratory Chow 5001, Ralston 
Purina Co., St. Louis, MO) and tap water ad  libitum. Rats were then randomly 
divided into four dietary groups (8 rats/group): (1) com oil diet supplemented 
with vitamin E (CQ+E); (2) com oil diet deficient in vitamin E (CO-E); (3) butter 
oil diet supplemented with vitamin E (BO+E); (4) butter oil diet deficient in 
vitamin E (BO-E). The composition of the CO-E diet Is listed in Table 1. The 
vitamin E deficient diets contained all other necessary nutrients a s  proposed by 
the National Research Council [National Research Council, 1978J. Vitamin E 
(RRR-aipha-tocopherol) and com oil (tocopherol stripped) were kindly provided 
by Eastman Chemical Company (Kingsport, TN). The tocopherol and 
cholesterol free butter oil were obtained from Source food Technology, Inc. 
(Burnsville, MN). All other dietary supplies, i.e., torula yeast, sucrose, vitamin 
mix, salt mix, L-methionine and cholesterol were purchased from United States 
Biochemical Co. (Cleveland, Ohio). Food consumption in each dietary group 
was measured and adjusted every two days so  that all rats consumed the sam e 
amount of food each week. Rat body weight was recorded every four weeks.
P reparationofR at Diets
Various rat diets were prepared In small batches (2.7 kg) every two 
weeks by slowly mixing the constituents to avoid heating, and stored at 4°C in
Table 1. Composition of CO-E diet
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Ingredients g/1 OOg
Torula yeast 35.35
Sucrose 42.00
Com oil, tocopherol stripped 14.50
Vitamin mix1 2.90
Mineral mix draper2 3.95
L-Methlonine 0.25
Cholesterol 1.00
Selenium (0.4 ppm)
1 The vitamin mixture provided: (in mg/100g of diet) ascorbic acid, 99;
inositol, 11; choline chloride, 16.S; p-amlnobenzoic acid, 11; niacin, 9.9; ribofla­
vin, 2.2; pyridoxine-HCL, 2.2; thiamin HCL, 2.2; calcium pantothenate, 6.6; 
biotin, 0.05; folic add, 0.2; vitamin B12, 0.003. In addition, the vitamin mixture 
contained: (in untts/100 g of diet) vitamin A acetate, 1980; calciferol (D3), 220.
3 The salt mix provided On mg/100 g of diet): C aC 03, 654; 00804*51-120,
0.72; Ca3(P 04)2, 1422; ferric citrate 64; MnSC^-HaO,5.5; potassium 
c itra te ^ O , 946; Kl, 0.16; KaHP04, 309; NaCI, 432; ZhC03, 1.8; and MgC03l 
164.
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air tight plastic containers purged with argon. To prepare vitamin E 
supplemented diets (CO+E or BO+E), an aliquot of alpha-tocopherol (100
I.U./kg diet) w as dissolved In small amount of ethanol (5 ml in 400 mg oil), then 
mixed gently with com oil or butter oil. The sam e amount of ethanol was added 
to com oli or butter oil when vitamin E deficient diets (CO-E or BO-E) were 
made.
C o llec tio n  o f  R a t  P la s m a
Rats were lightly anesthetized with metofane (2,2-Dlchloro-1,1-dlfluoro- 
ethyl methyl ether). A small segment from the end of each rat's tail w as cut off 
with a  sterilized razor blade. Blood w as collected in a  1.5 ml Eppendorf 
mlcrofuge tube containing 30 pi of UaJEDJA (75 mg/ml) a s  anticoagulant and 
centrifuged at 15,600 x g for 10 min a t 4°C in an Eppendorf centrifuge (Brink- 
mann Instruments, Inc., Westbury, NY). Plasma was collected and assayed for 
ascorbate and urate level within 2 hours. Plasm a from rats In the sam e dietary 
group w as pooled and used for oxidation experiments within two days. An 
aliquot of plasma w as frozen a t -80°C and used for determination of fatty add  
composition, triglyceride and cholesterol, a s  well a s  analysts of phospholipid 
composition.
Fattv Add Composition of Plasma
An aliquot of rat plasma w as transesterifled with boron trifluoride In 
methanol by heating for 15 min at 80°C. Fatty a d d  C21 was used a s  an
internal standard. After addition of distilled water, fatty acid methyl esters 
(FAMEs) were extracted with hexane. The hexane extract was evaporated 
under nitrogen and the residue taken up in dichtoromethane. Fatty ad d  methyl 
esters were analyzed by gas chromatography (Vartan, model 3700) equipped 
with a  SP™-2330 glass capillary column (60 meters long and 0.75 mm ID) 
(Supelco, Bellefonte, PA). The tem peratures at the Injection port and the 
hydrogen flame Ionization detector were 230°C and 260°C respectively. The 
initial temperature at the column was 140°C and final temperature was 210°C at 
an increasing rate of 3°C/min. Nitrogen was used as a  carrier gas.
Determination of Triatvceride
Plasma triglyceride levels from Individual rats were m easured 
enzymatically according to the method of Bucolo and David [Bucoto and David, 
1973]. A commercial kit obtained from Sigma Diagnostics (St. Louis, MO) was 
adopted to work with a  microtiter plate reader (Molecular Devices Corporation, 
Menlo Park, CA). In this assay, plasma triglycerides were hydrolyzed by 
lipoprotein lipase to glycerol and free fatty ad d s. The glycerol was then 
coupled with enzyme reactions catalyzed by glycerol kinase, glycerol-1 - 
phosphate dehydrogenase and dlaphorase. The resulting formazan had an 
absorbance at 490 nm. The Intensity of the color produced was directly 
proportional to the triglyceride concentration of p lasm a The concentration of 
triglyceride was calculated based on the absorbance of the blank, plasma and 
calibrator (Sigma Diagnostic, S t  Louis, MO) using the following equation:
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triglycerides (mg/dl) =[(Apt-m- - At*J/(A olltnto, - A***)]
♦(concentration of calibrator)
Determination of Cholesterol
R asm a total cholesterol from individual rats was determined by an 
enzymatic method [Allain et al.t 1974; Zoppi and Fentlft 1976] using a  microtiter 
plate reader (Molecular Devices Corporation, Menlo Park, CA). Cholesteryl 
esters were hydrolyzed by chotesteryl ester hydrolase to free cholesterol and 
fatty acids. Free cholesterol w as oxidized by cholesterol oxidase and the 
resulting hydrogen peroxide coupled with the peroxldase/phenot/4- 
aminoantipyrine system. The resulting quinoneimine product was m easured at 
500 nm. The plasma concentration of cholesterol was determined relative to 
free cholesterol standard curve.
Rat Plasma Oxidation
Two types of azo-Initiators were used to Initiate rat plasma oxidation, one 
is water soluble (ABAP), the other is lipid soluble (AMVN).
R asm a Oxidation Initiated bv ABAP. R asm a (1.5 ml) from rats fed the 
sam e diet was pooled and placed In bottom flat glass vials with caps open. 
Oxidation w as started by addition ABAP (the final concentration of ABAP was 
25 mM) into plasma. R asm a with ABAP was incubated a t 30°C and exposed 
to the air. At different time points, tipld hydroperoxide and vitamin E levels 
were determined by the methods described in the section 'lipid hydroperoxide
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measurement" and "consumption of alpha- and gamma-tocopheroi".
R asm a Oxidation Initiated bv AMVN. Plasma from rats fed the sam e 
diet was pooled and diluted with phosphate buffer saline (PBS) (1:1, v/v). The 
oxidation was performed a s  described above for the water soluble azo-initlator 
except 10 mM AMVN was used and plasma was incubated at 37°C instead of 
30°C. Preliminary experiments indicated that the experimental conditions for 
the plasma oxidation initiated by AMVN, i.e., dilution of plasm a and temperature 
of plasma Incubation (37°C), are appropriate for studying the oxidation kinetics 
in the presence of AMVN, because the oxidation kinetics can be observed 
within a  reasonable time (8 to 10 hours).
D e te rm in a tio n  o f A s c o rb a te
The ascorbate assay  was performed within 2  hours after blood collection. 
The plasma ascorbate levels in individual rats were determined colorimetricalfy 
in a  microttter plate reader (Molecular Devices Corporation, Menlo Park, CA) by 
a  modification of the Beuteler method [Beuteler, 1984]. Rat plasma (200 pi) 
w as mixed with 10 pi 3.0 M of trichloroacetic a d d  and centrifuged at 10,000 
rpm. The supernatant was mixed with phosphate buffer (0.5 M, pH 7.5) and 
tetrazolium salt (MTT). In sample blank, ascorbate oxidase (637.5 kU/l) was 
added to remove ascorbate In plasma. After incubating for 6 minutes at 37°C, 
the absorbance at 578 nm was recorded a s  A,. The 5-methylphenazJnium 
methosulphate solution (PMS, 15 mM) was added and mixed with both sample
and sample blank, and then Incubated at 37°C for another 15 minutes. In this 
reaction, ascorbate reduced the MTT to a  formazan in the presence of PMS. 
The absorbance (Aj) at 578 nm was recorded immediately. The absorbance 
change - A, *«*) of the blank was subtracted from the absorbance
change of the plasma (A ^___ - A, p.mTt). The absorbance difference was
proportional to the ascorbate level In the plasma. L-ascorbate was used as a  
standard for determining the concentration of ascorbate in the plasma.
Urate Measurement In Rat Plasma
Urate content In Individual rats w as determined enzymatically using a  uric 
acid determination kit (Sigma diagnostics, S t  Louis, MO). The uric ad d  was 
oxidized by urlcase to become attantotn, C 02 and HL,02. The HjO, reacts with 
4-amlnoantipyrine and 3,5-dichloro*2-hydroxybenzenesutfonate to form a  
qulnoneimtne dye which absorbs at 532 nm. This commerdal kit was adopted 
to a  microtiter plate reader (Molecular Devices Corporation, Menlo Park, CA).
Sulfhvdrvl Group (SH4 Assay
Sutfhydryl concentrations in plasma from rats fed various dietary groups 
were measured according to the method described by Elman [Ellman, 1959]. 
The assay was performed In a  microtiter plate with 5 ,5 '*dithiobis (2-nitrobenzoic 
add) (DTNB) a s  follows: 30 pi of plasma was mixed with 270 pi of 0.2 M 
NajHPO* (pH 9.0, containing 2 mM EDTA) and 20 pi of DTNB stock solution 
(10.0 mM In 0.035 M phosphate buffer a t pH 7). The absorbance at 412 nm
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was measured. L-cystelne was used a s  a  standard.
Cummene Hydroperoxide Consumption In Plasma
An aliquot of rat plasma was placed In a  Eppendorf microfuge tube at 
30°C water bath. Cummene hydroperoxide was dissolved in a  small amount of 
ethanol and then added to 10 mM PBS to obtain a  PBS stock solution. The 
stock solution of cummene hydroperoxide w as added to the plasma giving a  
final concentration of 1 mM. The concentration of cummene hydroperoxide in 
plasma w as measured a s  a  function of time by the method described under the 
method of measurement of lipid hydroperoxides. PBS containing 1 mM of 
cummene hydroperoxide was used a s  a  positive control.
Uoid Extraction of Plasma
Rat plasma (500 pVrat) was extracted by the modified method of Bifgh 
and Dyer [Bligh and Dyer, 1959] using methylene chloride Instead of chloroform 
[van Kuijk, 1965]. The solvent used during extraction w as 2  ml methanol, 2  ml 
dichloromethane containing 50 pg/ml BHT (2:1, v/v). The dlchloromethane 
phase containing lipids was dried over sodium sulfate and evaporated in a  Vlrtis 
model 10-030 freeze dryer (the Vlrtis Company, Inc. Gradiner, NY). The lipid 
residual was resuspended In chloroform and stored at 4°C.
Phospholipid Analysis bv TLC
Phospholipids of rat plasma and liver were separated by unldlmentional 
thin layer chromatography (TLC) by the method of Sherma and Touchstone
[Sherma and Touchstone, 1978]. Whatman LK5D precoated silica gel plates (5 
x 20 cm) were obtained from Fisher Scientific (Fair Lawn, NJ). These plates 
contain a  layer of 80 A silica gel above a  3 cm Inert preadsorbent layer, and 
are scored Into 9 mm wide lanes in the long direction. The layers were pre­
washed in chloform:methanol (1:1, v/v) and then oven dried a t 130°C for 15 
minutes. The lipid extracts were spotted on the preadsorbent area, then 
developed in an unsaturated glass tank. The mobile phase w as ethyl acetate: 
n-propanol: chloroform: methanol: 0.25% aqueous KCJ (25:2525:13:9 v/v). The 
mobile phase w as allowed to ascend to the top of the plate. The 
chromatogram w as air dried for 15 minutes, sprayed heavity with a  solution 
containing 10% CuSO« and 8% H3P 0 4. The lipids were visualized by heating 
the plate a t 170°C-180°C for 15 minutes. Phospholipid standards (Matreya,
Inc., Pleasant gap, PA) were used to identify each phospholipid subclass in rat 
plasma. The amount of each phospholipid w as determined by measuring the 
areas of spots using a  scanner and Sigma Scan Image analysis software 
(Jandel Scientific, Corte Madera, CA). The area of each lipid subclass was 
interpreted a s  a  percentage of the area of total phospholipids.
Statistical Analysis
A one-way or two-way ANOVA followed by Scheffe's test w as used to 
compare the fatty a d d  composition, plasma concentration of cholesterol, 
triglyceride, sulfhydryl group, ascorbate and urate in rats fed various diets. A p 
< 0.05 w as considered a s  statistically significant.
CHAPTER 3 
Results
Part I -  The Influence of Plasma Antioxidants on the Oxidation 
Kinetics of Human Lipoprotein
The Consumption of Tocopherol During LDL Oxidation
Alpha- and gamma-tocopherol are the major forms of tocopherol present 
In human LDL (see Figure 3). Figure 7 shows the HPLC chromatograms of 
tocopherol extracted from LDL oxidized with 15 mM ABAP at 30°C. Alpha- 
tocopherol (peak #3) was consumed more rapidly than gamma-tocopherol 
(peak #2), i.e., when LDL had been oxidized for 3.5 hours most of alpha- 
tocopherol disappeared while gamma-tocopherol remained almost unchanged. 
Gamma-tocopherol was consumed only after most of the alpha-tocopherol was 
oxidized. Eventually, both alpha- and gamma-tocopherol were depleted. Tocol 
(peak #1), an internal standard, remained constant from one run to another.
The Rate and Efficiency of Uotd Peroxidation Chain Initiation
Azo-initiators are  particularly useful for studying the oxidation of organic 
molecules because they provide quantitative kinetic Information. ABAP (A-N=N- 
A where A*= HCINHsCtCH^) is thermally labile and decom poses (see equation 
2) unimotecuiarty to generate free radicals (A4) at a  known constant rate. At 
30°C the rate of decomposition is equal to [ABAP]*k, where k,= 3.82 x 10‘7/sec
38
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Rgure 7. The chromatogram of tocol (paok #1), gamma-tocopherol (paak #2) 
and aJpha-tocopberol (paak #3) separated by reverse phase HPLC using a  
fluorescent detector. Tocol was used as an internal standard.
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at 30°C [Barclay, 1984].
A*N=N*A —> 2A* + Nj (2)
Not all the radicals generated by reaction (2) are, however, able to 
Initiate lipid peroxidation chain reactions. The actual rate of chain Initiation, R,, 
can be estimated from equation (3) where tj Is the induction time, i.e., the time 
required to consume all the tocopherol (alpha- plus gamma-tocopherol) present 
in an LDL sample.
R, = 2[tocopheroiJ/tj (3)
Rgure 8 shows the oxidation of a  typical human LDL sample in the 
presence of an air saturated solution containing 15.0 mM of the water soluble 
azo-initiator ABAP a t 30°C (no ascorbate or urate). For the data given In Figure 
8, R, w as 1.35 x 10* M/sec. The efficiency, e, at which the A* radicals initiate 
(ipid peroxidation chain reactions is given by equation (4).
e  = R, /  2k,([A-N=N-AD (4)
For the data In Rgure 8, the  efficiency, e, w as 0.23. The m ean efficiency for all 
five LDL oxidation experiments was 0.51+0.13 which is very simitar to the value 
found by others for the autoxidation of linoleic ad d  in SDS micelles at 30 CC 
using ABAP [Ohishl, 1985].
Lipoprotein Oxidation In the Absence of Water Soluble Antloxidants
Rgure 8 shows that while alpha- and gamma-tocopherol were present 
(I.e., during the induction period) the rate of lipid hydroperoxide (LOOH) 
formation in LDL was stow but linear with time. When ait the alpha-tocopherol
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Rgure 6. Tocopherol consumption and tipid hydroperoxide formation in human
LDL exposed to 15 mM water soluble free radical initiator ABAP in the absence
of ascorbate or urate. One experiment typical of six is shown.
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and gamma-tocopherol were consumed (about 2 hrs) the rate of lipid 
hydroperoxide formation significantly increased and remained linear. The rate 
of lipid hydroperoxide formation also provides an estimate of the chain length, 
v, which is a  m easure of the number of propagations per initiation 
[Barclay,1984]. A number greater than one indicates that LDL oxidation 
proceeds via a  free radical chain mechanism. For Figure 8, the chain length (v 
= (d[LOOH]/dt)/R,) before and after all the tocopherols were consumed was 10 
and 80, respectively. For all six LDL oxidation experiments chain lengths of 4.0 
± 1 .7  and 26.0 ±11.6, respectively, were found for LDL oxidation In the 
absence of either ascorbate or urate.
Lipoprotein Oxidation in the Presence of W ater Soluble Antioxidants
Figures 9 and 10 show the oxidation kinetics of one LDL sample In the 
presence of 50 pM of ascorbate or 50 pM urate, respectively. The insert In 
Rgure 9 shews the consumption of ascorbate during the oxidation experiment 
Stmilarty, the insert in Figure 10 shows the consumption of urate. The rate of 
lipid hydroperoxide formation during the Induction period was compared for the 
LDL sample in the absence of water soluble antioxidant (Rg. 8), in the 
presence of ascorbate (Rg. 9) or urate (Rg. 10). Ascorbate, but not urate, 
significantly reduced the rate of llptd hydroperoxide formation during the 
Induction period. After all the alpha- plus gamma-tocopherol was consumed, 
however, the rate of lipid hydroperoxide formation w as very similar for LDL 
samples oxidized under the three conditions (no water soluble antioxidant, 50
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Rgure 9. Tocopherol consumption and lipid hydroperoxide formation in human
LDL exposed to 15 mM water soluble free radical initiator ABAP in the presence
of 50 pM ascorbate. One experiment typical of six is shown.
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Rgure 10. Tocopherol consumption and lipid hydroperoxide formation In human
LDL exposed to 15 mM water soluble free radical initiator ABAP In the presence
of 50 pM urate. One experiment typical of six Is shown.
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pM initial ascorbate, or 50 pM initial urate). The rates of liptd hydroperoxide 
formation In Rg. 8, 9 and 10 is shown in Table 2. Table 3 summarizes the data 
for all six oxidation experiments. One-way ANOVA of all six oxidation 
experiments confirmed the conclusions drawn from the analysis of a  single 
oxidation experiment.
Both urate and ascorbate markedly increased the time required to totally 
consume either alpha- or gamma-tocopherol. The length of time required to 
consume alpha- plus gamma-tocopherol was increased by about 1.5 hr in the 
presence of 50 pM ascorbate and by 3.0 hr in the presence of 50 pM urate. 
These data indicate that urate was considerably more effective than ascorbate 
in delaying the time required for the  consumption of tocopherols. Urate was 
also consumed at a  significantly lower rate (-14,1 pM/hr) than ascorbate (-23.7 
pWhr) in the in vitro oxidation system s as shown by the inserts in Rgures 9 
and 10.
The Combined Effect of Ascorbate and Urate On LDL Oxidation
Rgure 1 1 ,1 2 ,1 3  and 14 show the oxidation kinetics of a  different LDL 
sample. Rgure 1 1 ,1 2 ,1 3  shows the oxidation of LDL in the absense or 
presence of 50 pM ascorbate or 50 pM urate respectively. Figure 14 shows the 
oxidation kinetics of LDL In the presence of 25 pM ascorbate and 25 pM urate. 
The Insert in Figure 14 shows the consumption of ascorbate and urate. 
Ascorbate was consumed rapidly and linearly with time. The rate of ascorbate 
consumption w as -24.6 pM/hr which Is very similar to the rate observed for
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Table 2. The influence of ascorbate or urate on rates of lipid 
hydroperoxide formation in LOL before and after the induction period (0*
Water-soluble
antioxidant
Rate of lipid hydroperoxide formation 
(nmol/mg/hr)
before t, after t,
none 41.2*4.3* 312.0*17.6?
50 pM Ascorbate 23.9±6.0b 319.0*11.2?
50 pM Urate 45.3*2.7* 305.5*29.9?
‘LDL isolated from an individual donor was oxidized in the presence of 15 mM 
ABAP as  indicated in the text. Data are expressed a s  mean±SEM. Values not 
sharing a  common letter (a,b,c,d) are significantly different at p < 0.05.
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Table 3. Summary of rates of liptd hydroperoxide formation In six LDL 
samples before and after the Induction period (t)*
Water-soluble
antioxidant
Rate of lipid hydroperoxide formation 
(nmol/mg/hr)
before t, after t,
none 54.0*8.1* 236.2*36.2?
50 pM Ascorbate 16.2*11.5b 226.0*32.4"
50 pM Urate 37.1*3.1* 206.6*29.1"
‘Data are  expressed a s  mean±SEM of six independent oxidation experiments. 
Values not sharing a  common letter (a.b.c.d) are significantly different at p < 
0.05.
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Figure 11. Oxidation kinetics of human LDL isolated from a  different donor. 
LDL was exposed to 15 mM water soluble free radical initiator ABAP in the 
absence of ascorbate and urate.
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Rgure 12. Oxidation kinetics of human LDL In the presence of 50 pM
ascorbate. LDL was Isolated from the same donor In FIg.11 and exposed to 15
mM water soluble free radical Initiator ABAP.
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Figure 13. Oxidation kinetics of human LDL In the presence of 50 pM urate.
LDL was isolated from the same donor in Fig.11 and exposed to 15 mM water
soluble free radical initiator ABAP.
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Rgure 14. Oxidation kinetics of human LDL in the presence of 25 pM
ascorbate and 25 pM urate. LDL was isolated from the sam e donor In Flg.11
and exposed to 15 mM water soluble free radical initiator ABAP.
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ascorbate in the absence of urate. Before ascorbate was completely depleted 
(within 1 hr), urate was consumed very slowty (the consumption rate was only - 
0.8 pM/hr). After ascorbate completely disappeared, urate was consumed more 
rapidly. The consumption rate was -12.1 pW hr which is similar to rate of urate 
consumption observed In the absence of ascorbate. In the presence of 
ascorbate (within 1 hour), both alpha- and gamma-tocopherol levels remained 
unchanged, which was similar to the observations for LDL oxidation In the 
presence of ascorbate alone a s  shown In Rgure 9 and Rgure 12. After 
ascorbate was consumed, the oxidation kinetics was similar to that in the 
presence of urate alone a s  shown in Rgure 10 and 13. The combined effect of 
25 pM ascorbate and 25 pM urate on delaying the time required for the 
consumption of tocopherots was more pronounced than that of 50 pM 
ascorbate alone but less effective than that of 50 pM urate alone, I.e., 4.0 hrs 
with 50 pM ascorbate (Rg.12), 5.5 hrs with 50 pM urate (Rg.13) and 4.5 hrs 
with 25 pM ascorbate plus 25 pM urate (Rg.14). Table 4 summarizes the rates 
of lipid hydroperoxide formation in Rgure 1 1 ,1 2 ,1 3  and 14. The rate of lipid 
hydroperoxide formation In the presence of 25 pM ascorbate and 25 pM urate 
was similar with that In the presence of 50 pM urate alone. Both of these rates 
were significantly different from those in the absence or presence of ascorbate 
(P<0.05).
The Curve Rt For Tocopherol Consumption
We found that the consumption of alpha- or gamma-tocopherol a s  a
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Table 4. The combination effect of ascorbate and urate on rates of lipid 
hydroperoxide formation In LDL before and after the induction period (t,)*
Water-soluble
antioxidant
Rate of lipid hydroperoxide formation 
(nmol/mg/hr)
before t, after t,
none 46.215.2* ^ .$ ± 3 .8 *
50 pM Ascorbate 22.8±3.0b 127.8±6.7d
50 pM Urate 34.4*0.7* 122,7±2.6d
25 pM Asc+25 pM Urate 31.7±2.3e 122.8±3.6d
*LDL isolated from a  different Individual donor was oxidized in the presence of 
15 mM ABAP a s  indicated In the text. Data are expressed a s  mean±SEM. 
Values not sharing a  common tetter (a,b,c,d) are significantly different a t p < 
0.05.
function of time could be curve fit to the modified sigmoidal equation, toc(t)= 
(toe0 + bt)/(1+(t/c)d), where toc(t) is the tocopherol (alpha- or gamma-) 
concentration at time t; toc° is the initial tocopherol concentration; b is the slope 
of the tocopherol consumption before its rapid oxidation phase; c is the time at 
the inflection potnt for tocopherol consumption and d is a  slope parameter 
during the rapid phase of tocopherol oxidation. This equation provided an 
excellent fit for LDL tocopherol consumption both In the presence or absence of 
water soluble antioxidants and was used to obtain the curves shown in Figures 
8-14. In general the values of the d slope parameter were between 5 and 18 
for all six LDL oxidation experiments. This implies that for time points before 
the Inflection point, c, the term (t/c)d Is small and equation (1) can be 
approximated by toc(t) « toe0 + bt, i.e., the consumption of tocopherol is 
approximately linear with time and the rate of linear consumption is given by the 
b parameter. A more negative value of b indicates a  greater rate of tocopherol 
consumption before Its rapid oxidation. At the inflection time point, c, equation 
(1) can be reduced to toc(c)n(toc° + bc)/2, i.e., the tocopherol concentration is 
half its initial value minus the linear consumption of tocopherol that occuned up 
to the inflection point.
Table 5 provides the linear slope parameter, b, and the inflection point 
parameter, c, obtained for alpha-tocopherol and gamma-tocopherol 
consumption for the data  presented in Rgure 8, 9 and 10. The linear 
consumption of alpha-tocopherol or gamma-tocopherol in the presence of either
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Table 5. The curve fit parameters for tocopherol consumption in the presence 
or absence of ascorbate or urate*
Water-soluble b c
antioxidants linear consumption 
(nmoles/mg/hr)
inflection 
time (hr)
None -4.42*0.16* 0.99*0.11*
Alpha- 50 pM Ascorbate -0.01 ±0.08" 2.07*0.01b
Tocopherol
50 pM Urate -0.95*0.05° 3.67*0.03°
none -0.66*0.07* 1.33*0.02*
Gamma* 50 pM Ascorbate -0.08*0,03hc 2.65*0.02**
Tocopherol
50 pM Urate •0.16*0.03° 4.25*0.04°
* Values a re  parameter ± SE from curve fit. The b parameter is the slope of the
tocopherol consumption before its rapid oxidation; c is the time at the inflection 
point for tocopherol consumption. For each tocopherol, the values in a  column 
without a  common letter (a,b,c,d) are significantly different (p <0.01)
ascorbate or urate was markedly lower than In the absence of these  water 
soluble antioxidants. Ascorbate was more effective than urate in reducing the 
linear rate of alpha-tocopherol consumption. The linear rate of alpha-tocopherol 
consumption, either in the absence of water soluble antioxidants or In the 
presence of urate, was greater than that of gamma-tocopherol. In the presence 
of ascorbate the linear consumption of both gamma- and alpha-tocopherol were 
found to be very low and not significantly different The inflection point data 
provided In Table 5 reinforces the qualitative conclusions drawn from the 
induction time periods. Urate (50 pM) tripled and ascorbate doubled the 
Inflection time point for alpha-tocopherol observed In the absence of water 
soluble antioxidants. The inflection time points for gamma-tocopherol were 
always greater than that of alpha-tocopherol.
Part II -  The Role of Dietary Fat and Vitamin E on Rat Plasma Oxidation 
Plasm a was isolated from age-matched male Flsher-344 rats fed diets 
either supplemented (+E) or deficient (-E) in vitamin E and containing either 
tocopherol stripped com oil (CO) or butter oil (BO) a s  the source of dietary fat 
(see table 1).
Food Consumption and Body Weight
Rats in each dietary group were given the same amount of food. The
food consumption was 10.5-11.5 g/day/rat and was not influenced by the age of
rats. The mean body weight of rats fed CO-E, CO+E, BO-E and BO+E diets
were almost identical at all time points (Fig. 15). Plasma vitamin E (alpha* 
tocopherol) level In rats fed various diets are given In Figure 16. Rats fed 
vitamin E deficient diets (CO-E or BO-E) for 5 weeks showed undetectable 
vitamin E in their plasma. Plasma from rats fed BO+E diets had higher vitamin 
E content compared to rats fed CO+E diets. There was a  significant difference 
in vitamin E levels between CO+E and BO+E by two-way ANOVA (p<0.05).
Fattv Acid Composition. Triotvceride and Cholesterol Levels
Plasma from rats fed com oil diets (CO-E or CO+E) showed significantly 
higher levels of polyunsaturated fatty ad d  (PUFA), lower levels of saturated 
fatty add  (SFA), and lower levels of monounsaturated fatty add  (MUFA), 
compared to plasma from rats fed the butter oil diets (BO-E or BO+E) (Table 
6). The fatty a d d  composition of plasma shown In Table 6 was similar with that 
of dietaiy fat (com oil or butter oil) (data not shown). The plasma content of 
C20:4n6 In rats fed com oil diets was slightly higher than that in rats fed butter 
oil diets, the statistical analysis (two-way ANOVA), however, showed only a  
marginally significant difference (p=0.06). The predominant plasma PUFA from 
rats fed CO diets was C182n6, which was about three fold higher compared 
with rats fed the BO diets. The ratios of PUFA/(SFA+MFA) in plasma from rats 
fed CO-E and CO+E diets were three fold higher than that observed for plasma 
in rats fed BO-E and BO+E diets. Vitamin E, however, did not influence the 
fatty acid composition, I.e., there was no significant difference for each type of
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Figure 15. Body weights (mean±SEM) of rats fed various diets. There w as no 
significant difference among m ean body weights of rats a t the sam e age.
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Rgure 16. Plasma alpha-tocopherol content (mean±SEM) In rats fed various 
diets. Alpha-tocopherol was m easured by reverse phase HPLC. Alpha- 
tocopherol In plasma from rats fed vitamin E deficient diets (CO-E and BO-E) 
w as undetectable. * Plasma from rats fed BO+E diets contained significantly 
higher vitamin E content than plasma from rats fed CO+E diet
Table 6. Effect of dietary fat and vitamin E on rat plasma fatty add composition
PUFA MUFA SFA Ratio
of
P/S+MC182n6 C20:4n6 Cl6:1n9 C18:1n9 C14:0 C16:0 C18:0
CO-E (7) 41.5*2.1** 11.2*1.5 2.3*0.3“ 17.8*2.8“ 0.3±0.1“ 20.1*1.4“ 6.8*0.9“ 1.11“
CO+E (6) 41.1*2.1“ 11.4±1.3 £8*0.7“ 17.9*1.4“ 0.2±0.1“ 19.9*1.5“ 6.7*0.7“ 1.11“
BO-E (6) 11.7*0.3* 9.3±0.8 5.7±0.4b 28.4±1.9b 2.0*0.2b 30.4*1 .(f 10.5*1.1b 0.27b
BO+E (5) 13.6*0.8? 8.5±0.5 28.4*1.8* 2^±0.2b 30.1*1.3b 10.5*0.9b 0.28b
* Data are expressed a s  mean*SEM. Values in a  column with different letters are significantly different 
ip  < 0.05).
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fatty add  between vitamin E supplement groups and vitamin E deficient groups.
Figure 17 shows the triglyceride and cholesterol levels in plasma from 
rats fed various diets. Plasma from rats fed butter oil diets (BO-E and BO+E) 
had significantly higher levels of triglyceride and cholesterol than plasma from 
rats fed com oil diets (CO-E and CO+E) (p<0.05). Vitamin E had no effect on 
plasma triglyceride and cholesterol levels, I.e., the plasma content of triglyceride 
and cholesterol between CO-E and CO+E or between BO-E and BO+E was not 
significantly different.
P h o sp h o lip id  C o m p o s itio n
Figure 18 shows the plasma composition of phospholipids, i.e., 
phosphatidyl ethanotamlne (PE), phosphatidyl Inositol (PI), phosphatidyl choline 
(PC), sphingomyelin (SPH) and lyso-phosphatidyl choline (Lyso-PC). PC was 
the major phospholipid In plasma from rats fed various diets. The plasma 
content of PE, PI, PC and SPH was not significantly different In rats fed various 
diets. Two-way ANOVA showed plasma lyso-PC contents were influenced by 
dietary fat-type, I.e., the mean lyso-PC content (16.0%±0.6) In plasma from rats 
fed com oil diets (16.1% for CO-E, 15.8% for CO+E) was higher than that 
(13.4%±0.6) in plasma from rats fed butter oil diets (13.7% for BO-E and 13.1% 
for BO+E) (p<0.05). The significant difference was, however, not seen  in 
Individual dietary group, l.e., lyso-PC level In CO-E (or CO+E) was not different 
than that In BO-E (or BO+E). Dietary vitamin E did not influence plasma levels 
of lyso-PC,
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Figure 17. Triglyceride and cholesterol levels in plasma from rats fed various 
diets. Triglyceride and cholesterol were determined by enzymatic method. Data 
are expressed a s  mean±SEM. * Values not sharing a  common symbol were 
significantly different a t p<0.05.
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Figure 18. Phospholipid composition in plasm a from rats fed various diets. 
Data are  expressed a s  mean±SEM (n-3). * The mean lyso-PC content in CO- 
E and CO+E was significantly higher than that in BO-E and BO+E (p<0.05).
Plasma Levels of Water Soluble Antioxidants
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We determined if dietary fat or dietary vitamin E could influence the 
levels of water soluble plasma antioxidants and thereby influence the kinetics of 
plasma oxidation. Table 7 summarizes the plasma levels of water soluble 
antloxidants, i.e., ascorbate, urate and sulfhydryl group, in rats fed various 
diets. Neither dietary fat nor vitamin E influenced the plasma content of these 
arrtioxidants. There was no statistically significant difference among the means 
for each antioxidant.
Plasma Oxidation Initiated bv a  Water Soluble Azo-initiator
Figure 19 shows the oxidation kinetics of plasma from rats fed com oil 
diets (left panel) and butter oil diets (right panel). The oxidation was initiated by 
addition of a  water soluble azo-initiator, ABAP at 30°C to give a  final 
concentration of 25 mM. Vitamin E was only detected in vitamin E supplement­
ed groups (CO+E or BO+E). The lipid hydroperoxide formation In plasma from 
rats fed various diets was linear with time. A t-test for comparing two slopes of 
linear regression w as used to compare the rates of lipid hydroperoxide 
formation In an experiment typical of three (see Rg. 19). The rates of lipid 
hydroperoxide formation (see Table 8) In plasma from rats fed butter oil diets 
(BO-E or BO+E) were markedly suppressed compared to the plasma from rats 
fed com oil diets (CO-E or CO+E). Surprisingly, plasma from rats fed vitamin E 
supplemented diets (C+E or B+E) showed higher rates of lipid hydroperoxide 
formation than those In plasma from rats fed vitamin E deficient diets (C-E or B-
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Table 7. Plasma levels of water soluble antioxidants In rats fed various diets*
Dietary 
Group (N)
Ascorbate (pM) Urate (jiM) Sulfhydryl group (pM)
CO*E (4) 30.7*1.9 28.2*2.2 111.6*15.1
CO+E (4) 33.6±2.9 29.8*5.5 106.4*28.3
BO-E (4) 22.0*1.7 32.8*2.7 149.9*11.1
BO+E (4) 27.7*3.9 21.0*2.4 125.8*11.0
* Data are expressed a s  mean±SEM. There was no significant difference 
among m eans for each antioxidant.
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Figure 19. Rat plasma oxidation initiated by 25 mM water soluble azo-initiator, ABAP, at 30°C. Lipid 
hydroperoxide formation (LOOH) and tocopherol consumption were measured a s  a  function of time. Left panel: 
Oxidation of plasma from rats fed com oil diets (high PUFA) either deficient in (C-E) or supplemented with 
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Table 8. The Influence of dietary fat and vitamin E on rates of lipid 
hydroperoxide formation in rat plasma oxidized in the presence of 
ABAP f l w )  or AMVN f l W
Rate of lipid hydroperoxide formation
(pM/hr)
A^MVN
CO*E 10.08±1.4* 31.98*1.9*
CO+E 15.70*1.4" 13.06*0.4"
BO-E 3.07*0.5° 5.26*0.4°
BO+E 5.26*0.4'* 2.87*0.3"
'Rat plasma was oxidized in the presence of either 25 mM ABAP or 10 mM 
AMVN a s  indicated in the tex t Data are expressed a s  sfope*SEM. Values 
in a  column not sharing a  common letter (a,b»c,d) are significantly different 
at p < 0.05.
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E). The difference among rates of lipid hydroperoxide was statistically different 
(p<0.05) (see Table 8). Simitar observations were also found In other two 
experiments.
Plasma Oxidation Initiated bv a Upld Soluble Azo-initiator
The plasma oxidation kinetics initiated by 10 mM lipid soluble azo- 
initiator, AMVN at 37°C is shown In Figure 20. Vitamin E was only detected in 
vitamin E supplemented groups (CO+E or BO+E). The tiptd hydroperoxide 
formation in plasma from rats fed various diets was linear with time. A t-test for 
comparing two slopes of linear regression was used to compare the rates of 
lipid hydroperoxide formation in an experiment typical of three (see Fig. 20).
The rates of lipid hydroperoxide formation In plasma from rats fed butter oil 
diets (BO-E or BO+E) (right panel) were markedly inhibited compared to the 
plasma from rats fed com oil diets (CO-E or CO+E) (left panel). Moreover, the 
rates of lipid hydroperoxide formation in plasma from rats fed vitamin E 
supplemented diets (CO+E or BO+E) were lower than those in plasma from 
rats fed vitamin E deficient diets (CO-E or BO-E). Table 8 summarizes the rate 
of lipid hydroperoxide formation during plasma oxidation in the presence of 
ABAP or AMVN. There were significant differences among rates of lipid 
hydroperoxide formation for each oxidation experiment (p<0.05).
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Figure 20. Rot plasma oxidation initiated fay 10 mM lipid soluble azo-initiator, AMVN at 37°C. Lipid 
hydroperoxide formation (LOOH) and tocopherol consumption were measured a s  a  function of time. Left panel: 
Oxidation of plasma from rats fed com oil diets (high PUFA) either deficient in (C-E) or supplemented with 
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The Ability of Plasm a to Detoxify Uold Hydroperoxides
Plasma contains an activity that consumes llpfd hydroperoxides. As 
shown In Figure 21, cumene hydroperoxide (100 pM) added to rat plasma was 
consumed as a  function of time. This activity was not, however, Influenced by 
vitamin E levels present in plasma, I.e., the consumption of cumene 
hydroperoxide in plasma from rats fed CO-E diet w as similar to that In plasma 
from rats fed CO+E (Figure 21, left panel). This observation was also 
duplicated In plasma from rats fed BO-E and BO+E diets (Figure 21, right 
panel). Dietary fat did, however, Influence the consumption of cumene 
hydroperoxide in plasma. Cumene hydroperoxide w as consumed more rapidly 
in plasma from rats fed CO diets (CO-E and CO+E) compared with plasma 
from rats fed BO diets (BO-E and BO+E), i.e., at 40 minutes after cumene 
hydropeorxide was added to plasma, about 80% of cumene hydroperoxide In 
plasma from rats fed CO diets was consumed, while only 40% of cumene 
hydroperoxide in plasma from rats fed BO diets was consumed.
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Figure 21. Cumene hydroperoxide consumption in rat plasma. Cumene hydroperoxide (100 pM) was added to 
plasma from rats fed various diets. The concentration of cumene hydroperoxide in plasma was measured a s  a  
function of time. PBS contorting 100 pM cumene hydroperoxide was used as a  control.
CHAPTER 4 
Discussion
The Influence of Plasma Antioxidants on the Oxidation 
Kinetics of Human Lipoprotein 
Increasing evidence supports the view that oxidative modifications to LDL 
Increase its atherogenicity. Vitamin E, ascorbate, ublquinoMO, lycopene and 
beta-carotene are plasma antioxidants that play a fairly well recognized role in 
preventing LDL oxidation. In contrast, the role of urate a s  an antioxidant 
capable of preventing LDL oxidation is not a s  well appreciated [Becker, 1993].
In the first part of this investigation, we compared the ability of urate and 
ascorbate to protect human LDL from in vitro oxidation.
The Role of Urate and Ascorbate on LDL Oxidation
In this study, urate was found to be more effective than ascorbate (50 
pM Initial concentration for both) in prolonging the time required to completely 
oxidize alpha-tocopherot and gamma-tocopherol in human LDL subjected to in 
vitro oxidation by aqueous peroxyl radicals. The ability of water soluble 
antioxidants to inhibit the oxidation of tocopherols is of particular physiological 
importance. Only after all tocopherol has been consumed is LDL oxidized to a  
form reported to be taken up by macrophages [Jessup e t ai., 1990]. 
Macrophages In the arterial Intima that have taken up large amounts of 
oxidatively modified LDL are thought to give rise to the foam celts observed In
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early atherosclerotic lesions.
Urate and ascorbate can both prevent oxidative dam age to LDL by 
quenching the aqueous free radicals that could otherwise Initiate lipid 
peroxidation chain reactions in LDL Evidence suggests, however, that 
ascorbate can regenerate tocopherol from the tocopheroxyl radicals in LDL 
[Sato e t al., 1990; Kagan, et al.,1992] but that urate does not exhibit this 
biochemical property [Sato et al„ 1990]. In the in vitro oxidation experiments 
reported here, the amount of tocopherol remaining at any time point represents 
the initial amount of tocopherol minus the amount consumed by oxidation plus 
any tocopherol regenerated from the tocopheroxyl radicals. In the presence of 
ascorbate (see Figure 9), the consumption of LDL tocopherols and the 
formation of lipid hydroperoxides was very low until most of the ascorbate was 
oxidized. The very low level of tocopherol consumption in the presence of 
ascorbate Is certainty consistent with the ability of ascorbate to regenerate 
tocopherol from tocopheroxyl radicals.
In contrast, LDL tocopherol consumption and the rate of lipid 
hydroperoxide formation in the presence of urate (see Figure 10) was greater 
than in the presence of ascorbate. Nevertheless, urate was consumed (see 
Insert in Figure 10) a t a  markedly slower rate than ascorbate (see insert in 
Figure 9) in the in vitro oxidation system. The net result was that urate was 
more effective than ascorbate in extending the time required to consume all 
LDL tocopherols (see Table 5).
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The combination of 25 pM urate and 25 pM ascorbate was found to be 
more effective on extending the lag phase than 50 pM ascorbate alone but less 
effective than 50 pM urate alone (see Figure 14), Moreover urate was 
consumed slowly while ascorbate was present (see insert in Figure 14), 
Indicating that ascorbate and urate act together in preventing LDL against in 
vito  oxidation.
LDL Tocopherols and Other Antioxidants
Alpha-tocopherol was always present in LDL at higher Initial levels than 
gamma-tocopherol. Nevertheless alpha-tocopherol was always totally depleted 
more rapidly than gamma-tocopherol In the in vitro oxidation system (see Table 
5 and Figures 8, 9 and 10). These data are consistent with the view (c.f. ref 
Nlkl, 1987) that alpha-tocopherol rapidly reacts with the gamma-tocopheroxyl 
radicals to give alpha-tocopheroxyl radicals and gamma-tocopherol.
There have been several studies attempting to define the relative 
importance of various plasma antioxidants in preventing lipoprotein oxidation. 
Som e investigators consider the temporal consumption of antioxidants and the 
degree to  which they inhibit the formation of lipid hydroperoxide to be of primary 
importance. It is known, for example, that ubiquinol-10 is consumed more 
rapidly, a s  a  percent of its initial level, than alpha-tocopherol In LDL exposed to 
aqueous peroxyl radicals and that ubiqulnol-10 suppresses the formation of lipid 
hydroperoxide formation better than alpha-tocopherol [Stocker, e t al., 1991). 
Ubtqulnol-10 might, therefore, be considered a  more effective antloxldant than
alpha-tocopherol from a  physicochemical point of view. It is, however, also 
important to consider the plasma concentrations of antioxidants a s  well a s  their 
ability to delay the consumption of LDL tocopherols. Each LDL molecule 
contains six to ten molecules of alpha-tocopherol but only about 0.7 molecules 
of ubiquinol-10. All 0.7 molecules of ubiqulnoMO molecules are consumed very 
rapidly when LDL is exposed to peroxyl radicals yet the level of alpha- 
tocopherol is decreased by only 5-10 percent [Niki, 1987] a t this time point and 
would not, therefore, be converted into hlgh-uptake atherogenic form of LDL
The Importance of Urate
The concentration of urate (300-395 pM) in human serum Is much higher 
than the level of ascorbate (30-50 pM). Urate contributes about 35-65 percent 
of the chain-breaking antioxidant capacity of human plasma while ascorbate 
contributes about 0-24 percent [Wayner e t a)., 1987]. Urate can form stable 
coordination complexes with iron Ions and inhibit Fa1*-catalyzed ascorbate 
oxidation and thereby stabilize ascorbate in biological fluids [Davies et a)., 1986; 
Sevan!an e t al., 1991]. The data presented In this investigation supports the 
view that urate should be considered a  major plasma antloxldant with the ability 
to considerably delay the oxidation of tocopherols in LDL and thereby prevent 
the conversion of LDL Into a  more atherogenic form.
The Mathematical Model of Oxidation Kinetics of Tocopherols
The empirical equation presented in this study, describing the oxidation
kinetics of tocopherols in the presence or absence of water soluble 
antioxidants, is useful for the quantitative s tud / LDL oxidation. As described 
previously (see Chapter 3, wider the section of The Curve Fit For Tocopherol 
Consumption), the equation provides an  excellent cun/e fit for LDL tocopherol 
consumption. The parameters of the equation can be used to compare the 
kinetics of tocopherol consumption when LDL is oxidized both in the absence or 
presence of water soluble antioxidants. It is difficult to draw any useful 
conclusions concerning the rapid phase of tocopherol oxidation described by 
the d parameter (see equation 1), particularly in the absence of water soluble 
antioxidants. This was due to the brief time on the rapid phase of tocopherol 
oxidation and the resulting large standard error of the d parameter.
Although there was much variation In the values of the fit parameters 
from experiment to experiment, the general conclusions described above from 
the data in Figures 8, 9 and 10 could also be m ade within the other individual 
oxidation experiments. Other investigators have also noted that the oxidation 
kinetics of LDL samples from different individuals can show variability. Not all 
the factors responsible for this variability In oxidation kinetics have been 
identified but the polyunsaturated fatty acid (PUFA) composition of the LDL is 
certainly an Important factor.
The Role of Dietarv_Fat and Vitamin E on Rat Plasma Oxidation
Dietary fat-type may be an important factor influencing lipid peroxidation 
in addition to plasma antioxidants. In the second part of this study, we studied
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the potential interaction between dietary fat and dietary vitamin E (alpha- 
tocopherol) on plasma oxidation.
Characteristics of Rat Plasma
The diets provided to the Fisher-344 rats resulted in the desired 
alterations in both plasma PUFA and plasma vitamin E. As shown In Table 6, 
rats fed com oil diets high In PUFAs had plasma fatty ad d  compositions with a 
high content of PUFA compared with rats fed butter oil diets which have a  high 
content of saturated fatty ad d s (SFA). This observation is consistent with that 
of other Investigators who have also found that fatty acid composition of 
lipoproteins was strongly modulated by dietary fat. For example, LDL isolated 
from rabbits fed a  variant sunflower oil containing a  high content of oleic acid 
(C18:1n9, 80%) and a  very low content of linoleic add  (C18:2n6, 8%) was 
highly enriched In oleic a d d  and very low in linoleic ad d  [Parthasarathy et a!., 
1990]. In a  human study, a  dietary supplementation of olive oil to 
normollpidemic healthy subjects resulted in lipoprotein enriched In oleic ad d  
[Avlram and Elas, 1993].
The diets given to rats also result in an alteration of plasma vitamin E 
content Plasma from rats fed -E diets (CO-E or BO-E) showed an undetectable 
amount of vitamin E (see Fig.16). Plasma levels of vitamin E In rats fed BO+E 
diet were higher than that in rats fed CO+E diet, despite the fact that the same 
amount of vitamin E was added to both the CO+E and BO+E diets and the food 
consumption of rats in these  two dietary groups was similar. The difference in
plasma vitamin E content appeared between rats fed CO+E and BO+E diets 
may be explained by the different fatty acid contents of the two diets. Vitamin 
E is absorbed into enterocytes passively during the process of intestinal lipid 
absorption. Vitamin E absorption, therefore, is facilitated by a  libera) intake of 
fat [Kayden and Traber, 1993]. Rats fed the BO+E diet had higher levels of 
plasma triglyceride than rats fed the CO+E diet, suggesting that In these rats, 
more vitamin E was absorbed from the intestine and secreted Into 
chylomicrons. Subsequently more vitamin E could be taken up by livers and 
secreted Into plasma lipoproteins. Many studies Indicate that plasma levels of 
vitamin E correlate with total plasma lipids because vitamin E is transported in 
plasma only by lipoproteins [Bjomson et al„ 1976; Behrens et al., 1982; 
Lambert and Mourot, 1984; Behrens and Madere, 1985; Traber and Kayden, 
1989]. Patients with lipoprotein lipase deficiency, who have elevated levels of 
triglyceride-rich lipoproteins (chylomicrons and VLDL), have about 10 times 
higher plasm a level of alpha-tocopherol than normal [Traber et a)., 1985; 
Traber, et al., 1992]. Alternatively plasma from rats fed the CO+E diet could 
have undergone In vivo oxidation to som e extent due to its high PUFA content.
Another possibility Is that rats fed CO+E and BO+E diets had different 
levels of hepatic tocopherol-binding protein. Tocopherol-binding protein 
transfers alpha-tocopherol from liver stores to nascent VLDL [Traber et a!„ 
1990; Traber et al., 1992]. Thus, this protein plays an important role in 
regulating plasma alpha-tocopherol levels by regulating the transfer of alpha-
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tocopherol Into VLDL It Is not known whether or not dietary fat-type influences 
the synthesis of alpha-tocopherol binding protein. Further investigation Is 
required to determine the levels of alpha-tocopherol binding protein in livers 
from rats fed com oil diets or butter oil diets.
Dietary fat-type influenced the plasma level of triglyceride (TG) and 
cholesterol (CHO). As shown in Fig. 17, rats fed PUFAs enriched com oil diets 
showed lower plasma levels of TG and CHO than rats fed butter oil diets. This 
observation was consistent with the view that a  diet rich in PUFA reduces 
plasma cholesterol level [Mattson and Grundy, 1985; Ahrens et al., 1957]. 
Dietary vitamin E content, however, did not influence the plasma levels of TG 
and CHO.
The Role of Dietary Fat on Plasma_Oxldation
In these  experiments, rat plasma oxidation was initiated by two types of 
azo-initiator, one was water soluble, ABAP, another is lipid soluble, AMVN. In 
both cases, the rates of lipid hydroperoxide formation in plasma from rats fed 
CO-E and CO+E diets were much higher than those In plasma from rats fed 
BO-E and BO+E diets (see Fig.19, Fig.20 and Table 8). These results indicate 
that plasma lipids from rats fed com oil diets (CO-E and CO+E) w as much 
more susceptible to in vitro oxidation In regardless of whether or not Initiating 
free radicals were generated in aqueous region or lipid region. Difference in 
plasma oxidation between rats fed the CO or BO diets w as not a  result of 
difference in the levels of water soluble antioxidants. Plasm a levels of
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ascorbate, urate and sutfhydryt group in rats fed different diets were not 
significantly different (see Table 7). Moreover, the difference in plasma 
oxidation can not be explained by a  difference in the activity of plasma to 
consume lipid hydroperoxides. As shown in Figure 21, cumene hydroperoxide 
was consumed faster in plasma from rats fed either CO-E or CO+E diets than 
that observed in plasma from rats fed BO-E or BO+E do ts.
The Role of Dietary Vitamin E on Plasma Oxidation
Vitamin E is the ma]or lipid soluble antioxidant preventing plasma lipids 
against oxidation. In these experiments, Figure 20 shows that plasma from rats 
fed vitamin E supplemented diets (CO+E or BO+E) had tower rates of lipid 
hydroperoxide formation when oxidation was initiated by a  lipid soluble azo- 
initiator, AMVN, compared with plasma from rats fed vitamin E deficient diets 
(CO-E or BO-E). This result was consistent with the view that vitamin E 
protects LDL from oxidation [Stone e t at., 1986; Jialal and Grundy, 1992; 
Esterbauer et al., 1991; Ma et al., 1994]. Vitamin E, however, showed an 
opposite effect when rat plasma was oxidized by a  water soluble azo-initiator, 
ABAP. As shown in Figure 19, plasma from rats fed CO+E or BO+E diets had 
higher rates of lipid hydroperoxide formation than plasma from rats fed CO-E or 
BO-E diets. This surprising result can not be explained by difference in plasma 
levels of water soluble antioxidants. As shown in Table 7, vitamin E did not 
influence the plasma levels of these antioxidants. This observation suggests 
that vitamin E can become a  prooxidant rather than an antioxidant under certain
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circumstances.
Recent studies have shown that when human LDL w as oxidized under
mild free-radical-initiated conditions, i.e., the initiating free radicals are in low
concentration, alpha-tocopherol accelerated LDL peroxidation, particularly when
LDL oxidation w as initiated by a  water soluble azo-initiator, ABAP [Bowry, et al.,
1992]. Based on their findings, Bowry and Stocker [Bowry and Stocker, 1993]
proposed that alpha-tocopherol (a-tocH) interacts with alkylperoxyl radicals
(ROD*) generated from ABAP (R-N=N-R) and become alpha-tocopheroxyl
radical (a-toc-) (see reaction 5 and 6).
Oa
R-N=N-R * R ----------- » ROO* (5)
ROO* + a*tocH --------- > ROOH + a-toc- (6)
When ROO* is present in high concentrations, a-toc* can trap a  second ROO* 
and produce a  nonradlcat product (NRP) (see reaction 7).
a-toc* + ROO------------> NRP (7)
When ROO* is low in concentration, the a-toc* species does not terminate 
(i.e., reaction 7) and therefore can interact with PUFA lipids (LH) to produce 
lipid peroxyl radicals (LOO*)(see reaction 8 and 9).
a-toc* + LH ----------- > L* + a-tocH (8)
L*+Oa ----------- > LOO* (9)
The LOO* produced interacts with a-tocH to produce lipid hydroperoxide 
(LOOH) and a-toc* (see reaction 10).
LOO* + a-tocH --------- > LOOH + a-toc* (10)
The a-toc- formed in reaction (10) can propagate iipid peroxidation by 
interacting with another LH as shown in reaction (8). During plasma oxidation 
induced by ABAP, free radicals were generated in the aqueous phase. Plasma 
contains a  number of antioxidants to quench the initiating free radicals (reaction 
5) before they could access to liptd phase. Moreover, initiating free radicals 
generated in the aqueous phase would only interact with the surface lipids of 
lipoproteins. Thus the flux of radicals having accessed to lipid molecules was 
low and a-toc* could not find a  terminating radical. Under these  circumstances, 
the a-toc* could Initiate lipid peroxyl radical formation with PUFA moieties.
When plasma oxidation was initiated by lipid soluble azo-initiator, AMVN, free 
radicals were generated In lipid phase and the entire lipid phase (surface and 
core lipids) can be accessed by free radicals and more terminating radicals are 
available for a-toc*. In this situation, the concentration of a-toc* would be low 
and, therefore, atpha-tocopherol would act a s  a  chain-breaking antioxidant to 
protect plasm a against lipid peroxidation.
Evaluation of Methods Used to Measure Plasma Susceptibility to Oxidation 
In our experiments, we used a  very sensitive method to m easure the 
formation of lipid hydroperoxide when plasma oxidation was initiated either by 
ABAP or AMVN. We found that not onty vitamin E but also the PUFA content 
of plasma was important in influencing the susceptibility of plasma to in vitro 
oxidation. Several methods have been developed by other investigators for 
determining the susceptibility of plasma to oxidation. The two main methods
are Total Radical-trapping Antioxidant Parameter (TRAP) and Oxygen-Radical 
Absorbance Capacity (ORAC) methods. The TRAP method relies on the time 
during which oxygen uptake Is Inhibited by plasma antioxidants [Wayner et al., 
1985]. This method requires an Q2 electrode to m easure 0 2 consumption and 
Is time consuming. The ORAC method Is a  fluorescence assay  based on the 
ability of a  dye (phycoerythrin) to be oxidized with the consequent loss of 
fluorescence [Cao et al., 1993]. This method is very sensitive and requires only 
a  few microliters of sample. In a  preliminary study from our lab (performed by 
Annong Huang) showed, however, that this assay was not sensitive to either 
the vitamin E or the PUFA content of rat plasma. Both TRAP and ORAC use 
only ABAP, a  water soluble azo-initiator to generate free radicals. These 
methods therefore primarily measure the radical-trapping ability of water soluble 
antioxidants. The results from this study dearly demonstrated that plasma 
PUFA content Is also an important factor Influendng the susceptibility of plasma 
to oxidation. Both the TRAP and ORAC methods are not sensitive to plasma 
PUFA content This study suggests that in order to adequately evaluate the 
effect of dietary factors on the susceptibility of plasma to oxidative damage, it is 
necessary to use both ABAP and AMVN to generate free radicals in different 
regions of llpid-protein complexes. Moreover, measurement of lipid 
hydroperoxide formation Is a  more direct method for evaluating the susceptibility 
of plasma to In vitro oxidation.
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Phospholipid Alterations
Although vitamin E deficiency has been shown to activate phosphollpase 
A,, and Inhibit the activity of lectthin:cholesterol acyttransferase (LCAT) (Pappu 
et al., 1978], we did not observe any difference In the plasma content of 
lysolecithln between rats fed vitamin E deficiency diets (CO-E or BO-E) and rats 
fed vitamin E supplemented diets (CO+E or BO+E), The dietary fat-type did, 
however, Influence the plasma level of lysolecithin, i.e., the mean lysoPC 
content in rats fed CO-E and CO+E diets was higher than that In rats fed BO-E 
and BO+E diets. The difference was, however, very small (about 16%). 
Preliminary studies from this lab on LDL oxidation (performed by Hal Wang, a  
graduate student In the Department of Chemistry and Pediatrics) indicated that 
lysolecithln increases the susceptibility of LDL to In vitro oxidation initiated by 
water soluble azo-initiator, ABAP. It is possible, therefore, that lysolecithln may 
contribute to the susceptibility of rat plasma to oxidation.
Ethanolamine plasmalogen (EtnPm) was shown to have antioxidant 
potential [Vance, 1990]. When phospholipids was isolated by traditional TLC 
method, the EtnPm band appears in the sam e position where phosphotidyl 
ethanolamin band is located [Synder, 1972]. As shown in Figure 18, the 
plasma PE content w as low and quite variable among rats fed the various diets. 
Moreover, two-way ANOVA analysis showed no significant differences in PE 
content among rats fed the various diets. Plasmalogen was not, therefore, 
considered to be a  fruitful avenue for further investigation.
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Comments on Dietary Fat
It has long been accepted that diets In which PUFAs are substituted for 
SFAs are healthy because PUFA enriched diets can lower plasma cholesterol 
levels [The National DIet-Heart Study, 1968]. Dietary Intervention studies have 
demonstrated that PUFA enriched diets reduce the risk of coronary heart 
disease p ay to n  et al., 1969]. It Is possible, however, that LDL In these 
patients Is more susceptible to oxidative modification but that the beneficial 
effect of PUFA enriched diets may compensate for the increased susceptibility 
to oxidation [Parthasarathy, 1990]. The data presented In this study 
demonstrate that com oil-enriched diets resulted In plasma more susceptible to 
lipid peroxidation. Butter oil Is more resistant to lipid hydroperoxide formation 
but K increases plasma levels of triglyceride and cholesterol which are  known to 
Increase the risk of coronary heart disease [Castetll, 1986; Kaukola et a!., 1980; 
Gotto et al.,1977; Barbir et at., 1988; Austin, 1988]. Recent studies suggest 
that diets enriched In olive oil (highly enriched with oleic acid, C18:1) as a  
dietary fat source are particularly beneficial because they not only lower plasma 
cholesterol level but also retard atherosclerosis by decreasing the susceptibility 
of LDL to oxidative damage [Grundy, 1986; Mensink, 1989; Aviram and Elas,
1993]. Moreover, plasma LDL levels and coronary heart disease rates are low 
in countries where oiive oil is used a s  a  major source of dietary fat [Masana et 
al., 1991; Baggio e t al., 1988; Sirtori et al., 1986]. Further Investigations are 
required before an olive oil-enriched diet Is recommended to the public.
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Conclusions
Our results from the second part of this study indicated that low dietary 
PUFA levels are more important in preventing the In vitro oxidation of plasma 
lipids than high dietary levels of alpha-tocopherol. Vitamin E w as found to be 
protective against lipid peroxidation when plasm a oxidation was initiated by a  
lipid soluble azo-in'rtiator, AMVN. Vitamin E, however, exhibited a  prooxidant 
effect when plasma oxidation was initiated by a  water soluble azo-in’rtiator, 
ABAP. This study provides useful Information for the design of future 
epidemiological or intervention studies related to lipid oxidation and 
cardiovascular disease.
BIBLIOGRAPHY
88
Ahrens, E  H., Hlrsch, J., Insull, W., TsaJtas, T. T„ Blomstrand, R., Peterson, M. 
L  1857. The influence of dietary fats on serum-Iipid levels in man. Lancet I: 
943-953.
Allain, C. C., Poon, L  S., Chan, C. G. S., Richmond, W., Fu, P. C. 1974. 
Enzymatic determination of total serum cholesterol. Clin. Chem. 20: 470-475.
Ames, B. N., Cathcart, R., Schwiers, E., Mochstein, P. 1981. Uric acid 
provides an antioxidant defense in humans against oxidant- and radical-caused 
aging and cancer: A hypothesis. Proc. Natl. Acad. Set. USA. 78:6858-6862.
Ardlle, N. G., Sellay, M. L , Simon, L  A  1989. Platelet activation by 
oxidatively modified low density lipoprotein. Atherosclerosis 76:117-121.
Austin, M. A  1988. Epidemiologic associations between hypertriglyceridemia 
and coronary heart disease. In: Seminars In Thrombosis and Hemostasis.
New York: Thieme Medical Publishers, Inc. p.137-142.
Aviram, M., Danker, G., Brook, J. G. 1990. Platelet secretory products 
increase low density lipoprotein oxidation, enhance its uptake by macrophages, 
and reduces its fluidity. Arteriosclerosis 10:559-563.
Aviram, M., Eias, K. 1993. Dietary olive oil reduces low-density lipoprotein 
uptake by m acrophages and decreases the susceptibility of the lipoprotein to 
undergo lipid peroxidation. Ann. Nutr. Metab. 37: 75-84.
Baggio, G., Pagnan, A , Muraca, M., Martini, S., Opportuno, A., Bonanome, M., 
Ambroslo, G. B„ Ferrari, S., Guarinl, P., Piccolo, D., Manzato, E., Corrocher,
R., Crepaldi, G. 1988. Olive-oil-enriched diet. Effect on serum lipoprotein 
levels and biliary cholesterol saturation. Am. J. Clin. Nutr. 47:960-964.
Barbir, M., Wile, D„ Trayner, I., Aber, V. R., Thompson, G. R. 1988. High 
prevalence of hypertrigtycerldaemta and apollpoprotein abnormalities In 
coronary artery disease. Br. Heart J. 60: 397-403.
Barclay, L  R. C., tocke, S. J., MacNeil, J. M., VanKessel, J., Burton, G. W., 
Ingold, K. U. 1984. Autoxidation of micelles and model membranes. 
Quantitative kinetic measurements can be m ade by using either water-soluble 
or lipid soluble initiators with water soluble or lipid soluble chain-breaking 
antioxidants. J. Am. Chem. Soc. 106: 2479-2481.
Becker, B. F. 1993. Towards the physiological function of uric acid. Free 
Radio. Blot. Med, 14:615-631.
89
Behrens, W. A., Thompson, J. N., Madere, R. 1982. Distribution of 
alpha-tocopherol in human plasma lipoproteins. Am. J. Clin. Nutr. 35:691-696.
Behrens, W. A., Madere, R. 1985. Transport of a- and r-tocopherol in human 
plasma lipoproteins. Nutr. Res. 5:167-174.
Beuteler, H.-O. 1984. In Bergmeyer, H. U. Ed. Methods of enzymatic 
analysis, vol. VI: p. 376-385.
Bierl, J. G., Tolliver, T. J., Catlgnanl, G. L  1979. Simultaneous determination 
of alpha-tocopherol and retinol in plasma and red blood cells by high pressure 
liquid chromatography. Am. J. Clin. Nutr. 32:2143-2149.
Bjorkham, I., Henriksson-Freyschuss, A., Breuer, O., DIczfaiusy, U., Berglund,
L , Henriksson, P. 1991. The antioxidant butylated hydroxytoiuene protects 
against atherosclerosis. Arterioscler-Thromb. 11(1): 15-22.
Bjornson, L  K., Kayden, H. J., Miller, E., Moshell, A. N. 1976. The transport of 
a-tocopherol and beta-carotene In human blood. J. Upid Res. 17:343-352.
Bligh, E. C., Dyer, W. J. 1959. A rapid method of total lipid extraction and 
purification. Can. J. Biochem. Physiol. 37: 911-917.
Bowry, V. W., Ingold, K. U., Stocker, R. 1992. Vitamin E in human low-density 
lipoprotein. Biochem. J. 288:341-344.
Bowry, V. W., Stocker, R. 1993. Tocopherol-mediated peroxidation. The 
prooxldant effect of vitamin E on the radical-initiated oxidation of human 
low-density tipoprotein. J. Am. Chem. Soc. 115:6029-6044.
Bruckdorfer, K. R. 1989. The effects of plasma lipoproteins on platelet 
responsiveness and on platelet and vascular prostanoid synthesis. 
Prostaglandins Leukot. Essent. Fatty Acids 38; 247-254.
Bucolo, G„ David, H. 1973. Quantitative determination of serum triglycerides 
by the use of enzymes. Clin. Chem. 19: 476-482.
Burton, G. W., Ingold, K. U. 1981. Autoxidation of biological molecules. 1. The 
antioxidant activity of vitamin-E and related chain-breaking phenolic antioxidants 
in vitro. J. Am. Chem. Soc. 103(21): 6472*6477.
Burton, G. W., Joyce, A., Ingotd, K. U. 1983. Is vitamin E the only 
lipid-soluble, chain-breaking antioxidant In human blood plasma and erythrocyte 
membranes? Arch. Biochem. Biophys. 221:281-290.
90
Burton, G. W., Hughes, L , Ingotd, K U. 1983. Antloxldant activity of phenols 
related to vitamin E. Are there chain-breaking antioxidants better than 
a-tocopherol? J. Am. Chem. Soc. 105: 5950-5951.
Burton, G. W., Ingold, K. U. 1986. Vitamin E: applications of the principles of 
physical organic chemistry to the exploration of Its structure and function. Acc. 
Chem. Res. 19; 194-201.
Burton, G., Traber, M. 1990. Vitamin E: Antloxldant activity, Biokinetics, and 
bioavailability. Annu. Rev. Nutr. 10:357-382.
Cao, G., Alessio, H. M.. Cutler, R. G. 1993. Oxygen-radical absorbance 
capacity assay for antioxidants. Free Radic. Biol. Med. 14:301-311.
Carew, T. E., Schwenke, D. C., Steinberg, D. 1987. Antiatherogenic effect of 
probucol unrelated to its hypocholesterolemlc effect: Evidence that antioxidants 
in vivo can selectively inhibit low density lipoprotein degradation In 
macrophage-rich fatty streaks stowing the progression of atherosclerosis in the 
WHHL rabbit. Proc. Natl. Acad. Sci. USA. 84:7725-7729.
Castelli, W. P. 1986. The triglyceride issue: A view from Framingham. Am. 
Heart J. 112:432-437.
Chisolm, G. M. 1991. Antioxidants and atherosclerosis: a  current assessm ent. 
Clin. Cardiol. 14(1): 25-30.
Ctevidence, B. A , Lehmann, J. 1989. Alpha- and gamma-tocopherol levels In 
lipoproteins fractionated by affinity chromatography. Uplds 24:137-140.
Cutler, R. G. 1991. Antloxldants and aging. Am. J . Clin. Nutr. 53:
373S-379S.
Davies, K. J. A , Sevanian, A , Muakkassah-kelty, S. F., Hochestein, P. 1986. 
Uric add-iron ion complexes. Biochem. J. 235:747-754.
Dayton, S., Pearce, M. L , Hashtmoto, S., Dixon, W. J., Tomiyasu, U. 1969. A 
controlled clinical trial of a  diet high In unsaturated fat in preventing 
complications of atherosclerosis. Circulation 40 (suppl.ll): II-1-II-63.
Dieber-Rotheneder, M., Puhl, H., Waeg, G., Strlegt, G., Esterbauer, H. 1991. 
Effect of oral supplementation with D-a-tocopherol on the vitamin E content of 
human low density lipoproteins and resistance to oxidation. J. Upid Res. 32: 
1325-1332.
91
Doba, T., Burton, G. W., Ingold, K. U. 1985. Antloxldant and co-antloxldant 
activity of vitamin C. The effect of vitamin C, either atone or in the presence of 
vitamin E or a  water-soluble vitamin E analogue, upon the peroxidation of 
aqueous muttilamellar phospholipid liposomes. Blochim. Biophys. A cta 835: 
298-303.
Edwards, A. L  1979 . Multiple regression and the analysis of variance and the 
covariance. Reading, England: W. H. Freeman and Co. p. 50.
Ellman, G. L  1959. Tissue sutfhydryl groups. Arch. Biochem. Biophys. 82: 
70-77.
Esterbauer, H., Dieber-Rotheneder, M., Striegl, G., Waey, G. 1991. Role of 
vitamin E in preventing the oxidation of low density lipoprotein. Am. J. Clin. 
Nutr. 53: 314S-321S.
Frei, B., Stocker, R., Ames, B. N. 1988. Antioxidant defenses and lipid 
peroxidation in human blood plasma. Proc. Natl. Acad. Sci. USA. 65: 
9748-9752.
Frei, B„ England, L , Ames, B. N. 1989. Ascorbate is an outstanding 
antioxidant In human blood plasma. Proc. Natl. Acad. Set. USA. 86: 
6377-6381.
Frei, B. 1991. Ascorbic acid protects lipid in human plasma and low-density 
lipoprotein against oxidative damage. Am. J. Clin. Nutr. 5 4 :1113S-1118S.
Gey, K. F., Brubacker, G. B., Stahelin, H. B. 1987. Plasma levels of 
antloxldant vitamins In relation to ischemic heart disease and cancer. Am. J. 
Clin. Nutr. 45:1368-1377.
Goldstein, J. L , Ho, Y. K., Basu, S. K , Brown, M. S. 1979. Binding site on 
macrophage that mediates uptake and degradation of acetylated low density 
lipoprotein producing massive cholesterol deposition. Proc. Natl. Acad. Set. 
USA. 76:333-337.
Gotto, A. M„ Gorry, G. A., Thompson, J. R., Cole, J, S., Trost, R., Yeshurun, 
D., DeBakey, M. E. 1977. Relationship between plasma lipid concentrations 
and coronary artery disease In 496 patients. Circulation 56: 875-883.
Grundy, S. M. 1975. Effects of polyunsaturated fats on lipid metabolism in 
patients with hypertriglyceridemia. J. Clin. Invest. 55:269-282.
Grundy, S. M. 1986. Comparison of monounsaturated fatty acids and
92
carbohydrates for lowering plasma cholesterol. N. Engl. J. Med. 314:745-748.
Haberland, M. E., Fong, D., Cheng, L  1988. Malondlaldehyde-attered protein 
occurs in atheroma of W atanabe heritable hyperlipidemic rabbits. Science.
241: 215-218.
Hafeman, D. G., Hoekstra, W. G. 1977. Upid peroxidation in vivo during 
vitamin E and selenium deficiency in the rat a s  monitored by ethane evolution. 
J. Nutr. 107: 666*672.
Hennlg, B., Chow, C. K. 1988. Upid peroxidation and endothelial cell injury: 
implications in atherosclerosis. Free Radic. Biol. Med. 4: 99-106.
Henriksen, T., Mahoney, E. M., Steinberg, D. 1983. Enhanced macrophage 
degradation of biologically modified low density lipoprotein. Arteriosclerosis, 3: 
149-159.
Hlral, K., Ohno, Y.t Nakano, T., Izutasni, K. 1984. Effects of dietary fats and 
phytosterot on serum fatty acid composition and lipoprotein cholesterol in rats.
J . Nutr. Vitaminoi. 30:101-112.
Hodges, R. E. 1979. Vitamins lecithin and additives. In Levy, R. I., Rifkind, B.
B. M.t Dennis, B. H., Ernest, N. E. Eds., Nutrition, lipids, and coronary heart 
disease. New York: Raven Press. p201-228.
Howell, R. R., Wyngaarden, J . B. 1960. On the mechanism of peroxidation of 
uric acids by hemoprotelns. J. Biol. Chem. 235: 3544-3550.
Ingold, K. U., Webb, A. C„ Witter, D., Burton, G. W., Metcalfe, T. A., Muller, D. 
P. R. 1987. Vitamin E remains the major liptd-sotuble, chain-breaking 
antioxidant In human plasma even In individuals suffering severe vitamin E 
deficiency. Arch. Biochem. Biophys. 259: 224-225.
Janero, D. R. 1991. Therapeutic potential of vitamin E in the pathogenesis of 
spontaneous atherosclerosis. Free Radical Biol. Med. 41:129-144.
Jessup, W., Rankin, S. M., deWhalley, C. V., Houtt, J. R. S., Scott, J., Leake,
D. S. 1990. Alpha-tocopherol consumption during low-density lipoprotein 
oxidation. Biochem. J. 265: 399-405.
Jialal, I., Grundy, S. M. 1992. Effect of dietary supplementation with 
alpha-tocopherol on the oxidative modification of low density lipoprotein. J.
Upid Res. 33:899-906.
93
Kagan, V. E., Serbtnova, E. A., Forte, T„ ScHa, G., Packer, L  1992. Recycling 
of vitamin E In human tow density lipoproteins. J. Upid. Res. 33: 385-397.
Kafyanaraman, B., Dartey-Usmar, V. M.t Wood, J., Joseph, J., Parthasarathy,
S. 1992. Synergistic interaction between the probucol phenoxyl radical and 
ascorbic acid in inhibiting the oxidation of low density lipoprotein. J. Biol.
Chem. 267(10): 6789*6795.
Kaukola, S., Mannlnen, V., Haionen, P . !. 1980. Serum lipids with special 
reference to HDL cholesterol and triglycerides in young male survivors of acute 
myocardial infraction. Acta Med. Scand. 208:41-43.
Kayden, H. J., Traber, M. G. 1993. Absorption, lipoprotein transport, and 
regulation of plasma concentrations of vitamin E in humans. J. Upid Res. 34: 
343-358.
Kellogg, E. W. I., Fridovich, I. 1977. Uposome oxidation and erythrocyte lysis 
by enzymically generated superoxide and hydrogen peroxide. J. Biol. Chem. 
252: 6721-6728.
Kita, T., Nagano, Y., Yokode, M., ishti, K., Kume, N., Ooshima, A., Yoshida, H., 
Kawai, C. 1987. Probuca) prevents the progression of atherosclerosis In 
W atanabe heritable hyperttpidemic rabbit, an animal model for familial 
hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 84:5928-5931.
Laemmit, U. K. 1970. Cleavage of structural proteins during the assembly of 
the head of bacteriophage T4. Nature 227:680-685.
Lambert, D., Mourot, J. 1984. Vitamin E and lipoproteins In 
hyperlipoproteinemia. Atherosclerosis 53: 327-330.
LeClair, I. O., Stone, W. L  1991. A sensitive assay  for measuring lipid 
hydroperoxides in low density lipoproteins. FASEB J. 5: A571.
Lewin, S. 1976. Vitamin C, Its Molecular Biology and Medical Potential. New 
York: Academic Press.
Uu, K., Cuddy, T. E., Pierce, G. N. 1992. Oxidative status of lipoproteins in 
coronary disease patients. Am. Heart J. 123:285-290.
Ma, Y-S., Stone, W. L , LeClair, I. O. 1994. The effects of vitamin C and urate 
on the oxidation kinetics of human low-density lipoprotein. P. S, E, B. M. 206: 
53*59.
94
Markwell, M. A. L S., Hass, S. M., Bleber, L  L , Tolbert, N. E. 1978. A 
modification of the Lowry procedure to simplify protein determination In 
membrane and lipoprotein samples. Anal. Biochem. 87:206-210.
Masana, L , Camprubi, M., Sarda, P., Sola, R., Joven, J .( Turner, P. R. 1991. 
The Mediterranean type diet: Is there a  need for further modification? Am. J. 
Clin. Nutr. 53:886-889.
Matsushita, S., Ibukl, F., Aoki, A. 1963. Chemical reactivity of the nucleic acid 
bases, I. Antioxidatlve ability of the nucleic acids and their related substances 
on the oxidation of unsaturated fatty acids. Arch. Biochem. Biophys, 102: 
446-450.
Mattson, F. H., Grundy, S. M. 1985. Comparison of effects of dietary 
saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids 
and lipoprotein In man. J. Upid Res. 26:194-202.
Menstnk, R. P., Groot, M. J. M., Broeke, L  T.( Severiinen-Nobles, A. P., 
Demacker, P. N. M. 1989. Effect of monounsaturated fatty acids and complex 
carbohydrates on serum lipoproteins and apoproteins In healthy men and 
women. Metabolism 38:172-178.
Meyers, D. G., Maloley, P. A. 1993. The antloxldant vitamins: impact on 
atherosclerosis. Pharmacotherapy 13(6): 574-582.
More], D. W., Hessler, J. R„ Chisolm, G. M. 1983. Low density lipoprotein 
cytotoxicity Induced by free radical peroxidation of lipid. J. Upid Res. 24: 
1070-1078.
Morel, D. W., DICorleto, P. E., Chisolm, G. M. 1984. Endothelial and smooth 
muscle cells alter low density lipoprotein In vitro by free radical oxidation. 
Arteriosclerosis 4: 357-364.
National Academy of Science. 1980. Recommended dally allowances. 
Washington, DC: Author.
National Research Council. 1976. Publication on nutrient requirements of 
laboratory animals. No. 10. Washington, D.C.: National Academy of Sciences.
Niki, E„ Saito, T., Kawakaml, A., Kamlya, Y. 1984. Inhibition of oxidation of 
methyl llnoleate In solution by vitamin E and vitamin C. J. Biol. Chem. 259: 
4177-4182.
Niki, E. 1987. Antioxidants in relation to lipid peroxidation. Chemistry and
95
Physics of Lipids 44:227-253.
Niki, E  1987. Upid antioxidants: How they may act In biological systems. Br. 
J. Cancer. 55:suppl.VIII, 153-157.
Niki, E  1991. Action of ascorbic acid as a  scavenger of active and stable 
oxygen radicals. Am. J. Clin. Nutr. 5 4 :1119S-1124S.
Ogihara, T„ Miki, M„ Kitagawa, M., Mino, M. 1988. Distribution of tocopherol 
among human plasma lipoproteins. Clin. Chim. Acta. 174:299-306.
Ohishl, N., Ohkawa, H., Miike, A., Tatano, T., Yagi, K. 19B5. A new method 
for lipid peroxides using a  methylene blue derivative. Biochem International 
10:205-211.
Oostenbrug, G. S., Mensink, R. P., Homstra, G. 1993. A moderate In vivo 
vitamin E supplement counteracts the fish-oil-induced Increase in in vitro 
oxidation of human low-density lipoproteins. Am. J. Clin. Nutr. 57 (suppfl: 
827S.
Pallnski, W. 1989. Low density lipoprotein undergoes oxidative modification in 
vivo. Proc. Natl. Acad. Sci. USA. 86:1372-1376.
Palinski, W., Yta-Herttuala, S., Rosenfetd, M. E , Butler, S. W., Socher, S. A., 
Parthasarathy, S., Curtiss, L  K., Witztum, J. L  1990. Antisera and monoclonal 
antibodies specific for epitopes generated during oxidative modification of low 
density lipoprotein. Arteriosclerosis 10:325-335.
Pappu, A. S., Fatterpaker, P., Sreenivasan, A. 1978. Role of vitamin E in 
cellular processes. Wid. Rev. Nutr. Diet. 31: 190-195.
Parthasarathy, S., Stelnbrecher, U. P., Barnett, J., Witztum, J. L  1985. 
Essential rote of phosphotipase Aj activity in endothelial cell-induced 
modification of low density lipoprotein. Proc. Natl. Acad. Sci. USA. 82: 
3000-3004.
Parthasarathy, S., Young, S. G., Witztum, J. L , Pittman, R. C., Steinberg, D. 
1986. Probucal inhibits oxidative modification of low density lipoprotein. J. Clin. 
Invest. 77:641-644.
Parthasarathy, S., Printz, D. J., Boyd, D„ Joy, L , Steinberg, D. 1986. 
Macrophage oxidation of low density lipoprotein generates a  modified form 
recognized by the scavenger receptor. Arteriosclerosis 6:505-510.
96
Parthasarathy, S. P., Khoo, J. C„ Miller, E., Barnett, J., J.L , W., Steinberg, D.
1990. Low density lipoprotein rich in oteic acid Is protected against oxidative 
modification: implications for dietary prevention of atherosclerosis. Proc. Natl, 
Acad. Sci. 87: 3894-3898.
Plachta, H., Bartnlkowska, E , Obara, A. 1992. Upid peroxides in blood from 
patients with atherosclerosis of coronary and peripheral arteries. Clfnica 
Chimica Acta 211:101 -112.
Princen, H. M., van Poppel, G. G., Vogelezang, C., Buytenhek, FI, Kok, F. J. 
1992. Supplementation with vitamin E but not b-carotene In vivo protects low 
density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking. 
Arterloscler. Thromb. 12: 554-562.
Quinn, M. T., Parthasarathy, S., Steinberg, D. 1985. Endothelial-cell derived 
chemotactlc activity for mouse peritoneal m acrophages and the effects of 
modified forms of low-density lipoprotein. Proc. Natl. Acad. Sci. USA. 82: 
5949-5953.
Quinn, M. T., Parthasarathy, S., Fong, L  G., Steinberg, D. 1987. Oxidatively 
modified low-density lipoproteins: a  potential role In recruitment and retention of 
monocytes/macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA.
84: 2995-2998.
Quinn, M. T., Parthasarathy, S., Steinberg, D. 1988. Lysophosphatldylcholine: 
A chemotactlc factor for human monocytes and its potential rote In 
atherogenesis. Proc. Natl. Acad. Sci. USA. 85:2805-2809.
Rice-Evans, C., Bruckdorfer, K. R. 1992. Free radicals, lipoproteins and 
cardiovascular dysfunction. Molec. Aspects Med. 13:1-111.
Rosenfetd, M. E , Palinski, W., Yla-Herttuala, S., Butler, S., Witztum, J. L  1990. 
Distribution of oxidation specific liptd-proteln adducts and apolipoprotein B In 
atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis, 
10: 336-349.
Ross, R. 1986. The pathogenesis of atheroscierosisOan update. N. Engl. J. 
Med. 314:488-500.
Rudel, L  L , Parks, J. S., Bond, M. G. 1986. Dietary polyunsaturated fat 
effects on atherosclerosis and plasma lipoproteins in African green monkeys.
In Scarpelli, D. G., Migakl, G. Eds. Nutritional Diseases: Research Directions in 
Comparative Pathobiology. New York: A. R, Uss, Inc. p.501-523.
Sato, K., Niki, E., Shim asakI, H. 1990, Free radical-mediated chain oxidation
97
of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin
C. Arch. Biochem. Biophys. 279: 402-405.
Schwartz, S. M., Campbell, G. R., Campbell, J. H. 1986. Replication of 
smooth muscle cells In vascular disease. Circ. Res. 58:427-444.
Schwartz, C. J., Valente, A. J., Sprague, E  A., Kelley, J. L , Nerem, R. M.
1991. The pathogenesis of atherosclerosis-an overview. Clin Cardiol. 14(1): 
1-16.
Sevanian, A., Davies, K. J. A., Hochstefn, P. 1991. Serum urate a s  an 
antloxldant for ascorbic acid. Am. J. Clin. Nutr. 5 4 :1129S-1134S.
Sherma, J., Touchstone, T. J. 1979. Separation of amniotic fluid phospholipids 
by one-dimensional TLC. HRC CC. 2:199-200.
Simon, M. I., Van Vunakis, H. 1964. The dye-sensitized photooxidation of 
purine and pyrimidine derivatives. Arch. Biochem. Biophys. 105:197-206.
Sirtori, C. R., Tremoli, E , Gatti, E , Montanari, G., Sirtori, M., Colli, S., 
Giarrfranceschl, G., Madema, P., Dentone, C. Z , Testolin, G.t Galli, C. 1986. 
Controlled evaluation of fat intake in the Mediterranean diet: Comparative 
activities of olive oil and com oil on plasma lipids and platelets In high risk 
patients. Am. J. Clin. Nutr. 44:635-642.
Sparrow, C. P., Parthasarathy, S., Steinberg, D. 1989. A macrophage receptor 
that recognized low density lipoprotein but not acetylated low density 
lipoprotein. J. Biol. Chem. 264(5): 2599-2604.
Steinberg, D. 1983. Lipoproteins and atherosclerosis: a  look back and a  look 
ahead. Arteriosclerosis 3; 283-301.
Steinberg, D., Parthasarathy, S., Carew, T. E , Khoo, J. C., Witztum, J. L  
1989. Beyond cholesterol: Modifications of iow-density lipoprotein that increase 
its atherogenlcity. N. Engl. J. Med. 320:915-924.
Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L , Stelnber, D. 
1984. Modification of low density lipoprotein by endothelial cells involves lipid 
peroxidation and degradation of low density lipoprotein phospholipids. Proc. 
Natl. Acad. Sci. USA. 81: 3883-3887.
Stocker, R., Bowry, V. W., Frei, B. 1991. UbiqutnoI-10 protects human low 
density lipoprotein more efficiently against lipid peroxidation than does 
a-tocopherol. Proc. Natl. Acad. Sci. USA. 88:1646-1650.
98
Stone, W. L  1975. Hydrophobic interactions of alkanes with liposomes and 
lipoproteins. J. Biol. Chem. 250: 4368-4370.
Stone, W. L , Stewart, M. E , Nicholas, C., Pavuturl, S. 1986. The effects of 
dietary selenium and vitamin E on plasma cholesterol levels In male rats. Ann. 
Nutr. Metab. 30:94-103.
Stone, W. L  1988. Effects of dietary selenium and/or vitamin E on plasma 
lipoprotein cholesterol levels in male rats supplemented with cholesterol. Nutr 
Res. 8:1061-1071.
Stringer, M. D.( Gorog, P. G., Freeman, A., Kakkar, V. V. 1989. Upid 
peroxides and atherosclerosis. Br. Med. J. 298: 281-284.
Tatelshi, T., Yoshimlne, N.t Kuzuya, F. 1987. Serum lipid peroxide assayed by 
a  new colorimetric method. Exp. Gerontol. 22:103-111.
The National Diet-Heart Study. 1968. American Heart Association Monograph 
No. 18. New York: Am Heart Assoc.
Traber, M. G., Olivecrona, T„ Kayden, H. J. 1985. Bovine milk lipoprotein 
lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in 
vitro. J. Clin. Invest. 75:1729-1734.
Traber, M. G.t Kayden, H. J. 1989. Preferential incorporation of a-tocopherol 
vs r-tocopherol in human lipoproteins. Am. J. Clin. Nutr. 49:517-526.
Traber, M. G., Burton, G. W., Ingold, K. U., Kayden, H. J. 1990. RRR- and 
SRR-a-tocopherols are secreted without discrimination in human chylomicrons, 
but RRR-a-tocopherot Is preferentially secreted in very low density lipoproteins. 
J. Upid Res. 31:675-685.
Traber, M. G., Burton, G. W., Hughes, L, Ingold, K. U., Hidaka, H., Malloy, M., 
Kane, J„  Hyams, J., Kayden, H. J. 1992. Discrimination between forms of 
vitamin E by humans with and without genetic abnormalities of lipoprotein 
metabolism. J. Upid Res. 33:1171-1182.
Vance, J. E. 1990. Upoproteins secreted by cultured rat hepatocytes contain 
the antloxldant 1-alk-1-enyI-2-acyiglycerophosphoethanolamtne. Bfochlm. 
Biophys. Acta. 1045: 128-134.
Vankuijk, F. J. G. M., Thomas, D. W., Stephens, R. J., Dratz, E  A. 1965. J. 
Free Radicals Biol. Med. 1:215-219
99
Wayner, D. D. M., Burton, G. W., Ingold, K. U.. Locke, S. 1985. Quantitative 
measurement of the total, peroxyl radical-trapping antloxldant capability of 
human blood plasma by controlled peroxidation. FEBS Lett. 187:33-37.
Wayner, D. D. M., Burton, G. W., tngotd, K. U., Barclay, L  R. C. 1987. The 
relative contributions of vitamin E, urate, ascorbate and proteins to the total 
peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim. 
Biophys. Acta. 924: 408-419.
Working Group of Atherosclerosis of the National Heart Lung and Blood 
Institute. 1981. Washington, DC: US Government Printing Office.
Yamamoto, Y., Haga, S., Niki, E., Kamiya, Y. 1984, Oxidation of methyl 
linoleate in aqueous dispersion. Bull. Chem. Soc. Japan. 57:1260-1264.
Zoelier, R. A., Morand, 0 . H.( Raetz, C. R. H. 1988. A possible rote for 
ptasmatogens In protecting animat cells against photosensitized killing. J. Biol. 
Chem. 263:11590-11596.
Zoppl, F., Fenili, D. 1976. Enzymatic determination of total serum cholesterol 
with the Vickers D-300 analyzer. Clin. Chem. 22:690-691.
Persona) Data: 
Education:
Professional
Experience:
Publications: 1.
2 .
3.
100
VITA
YANSHANMA
Date of Birth: May 5 ,1962
Place of Birth: Guangzhou, P. R. China
Medical School of Sun Yat-sen University of Medical 
Sciences, Guangzhou, P. R. China, M.D., 1964
Graduate School of Sun Yat-sen University of Medical 
Sciences, Guangzhou, P. R  China, Neurology, Master of 
Medicine, 1987
East Tennessee State University, Jam es H. Quillen College 
of Medicine, Johnson City, TN, Biomedical Sciences with 
emphasis In Biochemistry, Ph.D., 1994.
Graduate Assistant and Research assistant I, Department 
of Biochemistry and Pediatrics, Jam es H. Quillen College of 
Medicine, East Tennessee State University, Johnson City, 
Tennessee, 1990-1994
Research associate and interim director of Lab. of 
Immunology, Guangdong Provincial Institute of Geriatric 
Medicine, Guangzhou, P. R. China, 1987-1989
Resident, Dept, of Neurology, The First Affiliated Hospital of 
Sun Yat-sen University of Medical Sciences, Guangzhou, P. 
R. China, 1984-1987
Ma, Y., Uu, M., and Zhang, J. HLA and myocardial 
Infarction. Central-South Chinese Geriatrics 5:(1), 106-107, 
1988
Qian, C., Ma, Y. and Fang, K. Investigation on the 
correlation of computed tomography to clinical practice in 
patients with mutti-infarct dementia. J. China Neurological 
and Mental Diseases 17:(6), 336-338,1991 
Ma, Y., Stone, W. L  and LeClair, I. O. The effects of 
vitamin C and urate on the oxidation kinetics of human low- 
density lipoprotein. Proceedings of the Society for 
experimental Biology and Medicine 206:53-59,1994 
Stone, W. L , LeClair, L  0 . and Ma, Y. The role of RRR- 
alpha-tocopherot on the oxidation of rat lipoproteins. The
101
FASEB Journal 6:(5),1992
5. Ma, Y., Stone, W. L  Tan, Z. and LeClair, I. O. The
Influence of vitamin E, urate and ascorbate on the oxidation
kinetics of human low density lipoprotein. The FASEB 
Journal 7:(3), A 415 ,1993
6. Stone, W. L , Huang, T., Ma, Y. and Wang, H. Dietary fat,
vitamin E and plasma oxidation. Free Radical Biology and 
Medicine, 533,1993
7. Ma, Y., Stone, W. L, Huang, T. and Wang, H. The role of
dietary polyunsaturated fatty acids (PUFAs) and vitamin E 
in plasma oxidized by a  water soluble azo-initiator. FASEB 
Journal 8:(5), A 734 ,1994
Honor and Awards:
1. Second place winner In The 8th and 10th Annual Student 
Research Forum, East T ennessee State University, 1992 and 
1994
2. Invited speaker at the minisymposium entitled "Metabolic Effects 
of Vitamin E in Health and Disease1 In Experimental Biology, New 
Orleans, April, 1993.
